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ABSTRACT
ESTRADIOL ENHANCES INFLAMMATION DURING PUBERTAL
DEVELOPMENT IN FEMALE MICE
MAY 2017
AMARYLIS VELEZ-PEREZ, B.A., UNIVERSITY OF PUERTO RICO MAYAGUEZ
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Jeffrey D. Blaustein
There is a dynamic interaction between the immune, endocrine, and central nervous
systems. The main function of the immune system is to protect the organism from
pathogens by engaging a network of organs, cells and signaling molecules. Recently, the
resident-immune cells of the brain have been found to be critical in supporting the full
development of neural circuits during sensitive periods of development. However, overactivation of the immune system during this period can alter the typical trajectory of
maturing neural circuits. LPS (lipopolysaccharide) administration decreases hormoneinduced adult sexual behavior in mice when administered during puberty, but not when it
is administered in other developmental periods. In addition to this, pubertal females show
increased microglial reactivity in hypothalamic areas associated with reproduction,
compared to adult females receiving the same treatment. Interestingly, removing the
ovaries of pubertal animals prior to LPS treatment ‘protects’ females from the decrease in
sexual behavior. Together, these data suggest that the ovaries are a key factor in
conferring vulnerability to LPS during puberty. Microglia express estrogen receptors,
which suggest that estradiol can modulate microglial reactivity. However, it is unknown
if estradiol regulates microglial reactivity during the pubertal sensitive period. The work
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presented in this dissertation was designed to test the hypothesis that estradiol confers
vulnerability to LPS by regulating microglial reactivity. We manipulated estradiol levels
using three approaches: (a) by ovariectomy (Chapter 2), (b) by estradiol capsule
implantation in ovariectomized females (Chapter 3), and (c) administration of an
aromatase inhibitor to gonadally intact females (Chapter 4). The core findings of this
work are: (1) estradiol affects microglial reactivity by increasing microglial outgrowth,
(2) there is heterogeneity in microglial reactivity among brain regions, (3) there is
heterogeneity in microglial reactivity within brain regions following immune activation,
(4) LPS causes a strong hypothermic response only in the presence of estradiol, and (5)
LPS induces higher levels of pro-inflammatory cytokines in the presence of estradiol.
The present work suggests that estradiol enhances immune surveillance during the
pubertal sensitive period. This work adds to the mounting evidence involving microglia
in normal developmental processes. Understanding the interaction between the endocrine,
immune and central nervous systems in females may shed light into factors that promote
a sex bias in the prevalence of mood and immune-related disorders, the onset and
progression of which emerge during the reproductive years in females.
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CHAPTER 1
THE INTERACTION BETWEEN ESTRADIOL AND MICROGLIA DURING
SENSITIVE PERIODS OF DEVELOPMENT
Introduction
Sensitive periods of development are time windows during which the effects of
experience are unusually strong (Knudsen, 2004). In the past, our laboratory has seen that
an immune challenge (induced by lipopolysaccharide; LPS) during puberty alters how
females respond to hormone treatment in adulthood. The long-term effect of this immune
challenge is only seen when LPS is administered during puberty, not prior to or after
puberty. Interestingly, removing the ovaries prior to administering LPS during pubertal
development protects females from the detrimental effects of LPS. This suggests that
ovarian secretions might be conferring vulnerability to LPS. Pubertal microglia react
more strongly to LPS, compared to adult microglia. In addition to this, emerging data
implicates microglia in processes that refine brain regions during sensitive periods of
development. The basis for this work stemmed from the observation that the presence of
the ovaries at the time of LPS conferred long-term vulnerability to LPS. Our core
hypothesis was that estradiol is the proximate cause in conferring vulnerability to LPS.
Microglia express estrogen receptors (Sierra, Gottfried-Blackmore, Milner, McEwen, &
Bulloch, 2008). However, it is unknown if steroids of ovarian source are implicated in
vulnerability to LPS during sensitive periods of development. In order to test this
hypothesis, we manipulated the estradiol environment using three approaches: a) by
ovariectomy (Chapter 2), b) by estradiol capsule implantation in ovariectomized females
(Chapter 3), and c) administration of an aromatase inhibitor to gonadally intact females
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(Chapter 4). This chapter will review the interaction between estradiol and microglia
during sensitive periods of development.
Pubertal Development
Puberty is emerging as a sensitive period during which particular stressors can
reorganize brain circuits permanently (Avital & Richter-Levin, 2005; Blaustein, Ismail,
& Holder, 2015; Green & McCormick, 2013). Puberty is a maturational process during
which an organism achieves reproductive competence (Sisk & Foster, 2004).
Importantly, puberty is a developmental stage with gradual, yet somewhat defined,
quantitative changes in the way the reproductive axis responds to internal and external
inputs. The process leading to pubertal onset, maturation and culmination involves a
myriad of genes regulating growth, energy balance, metabolism, and circadian rhythms
(Lomniczi, Wright, & Ojeda, 2015). These signaling events are integrated in the brain
where they signal readiness for pubertal maturation. Our current understanding of key
regulators of pubertal development is the result of genetic, molecular, cellular and
electrophysiological approaches that advance, delay or block pubertal maturation (Frazao
et al., 2013; Han et al., 2005).
One of the hallmarks of puberty is the maturation of the reproductive axis, which
results in the secretion of gonadal steroid hormones. In turn, gonadal steroid secretions
impact neurobiological processes regulating reproduction at the molecular, cellular,
physiological and behavioral levels. Some of the mechanisms by which neural circuits
are established and consolidated during sensitive periods of development include synaptic
pruning, axonal remodeling, and synapse consolidation. These events alter neural circuit
architecture, and estradiol has been implicated in some of these processes, particularly
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during the well-studied neonatal period. The brain’s immune cells are emerging as
critical players in typical neurodevelopmental processes during critical windows of
development by surveying the microenvironment, targeting immature synapses and
phagocytosing cellular debri.
Puberty refers to the development and maturation of the reproductive axis, which
includes brain regions regulating ovarian development, estrous cycle, and the ability to
display reproductive behavior (Sisk & Foster, 2004). On the other hand, adolescence is
the maturation of adult social and cognitive phenotypes (Sisk & Foster, 2004). Therefore,
although puberty and adolescence overlap in their timing, they are distinct events that
support biological events leading up to a mature adult organism (Sisk & Foster, 2004).
GnRH (gonadotropin releasing hormone) neurons are the final output of a
network of brain regions and signaling molecules regulating female fertility (Clarkson,
Han, Liu, Lee, & Herbison, 2010). The process leading to pubertal onset, maturation and
culmination is characterized by quantifiable changes in the reproductive axis. In some
rodents, sheep, and primates a gradual diurnal increase in pulsatile luteinizing hormone
(LH) is the first endocrine manifestation of pubertal onset (Lomniczi et al., 2013). The
first external sign of pubertal onset is the canalization of the vagina, which is dependent
on estradiol secretion (Rodriguez, Araki, Khatib, Martinou, & Vassalli, 1997). Puberty
culminates with the occurrence of first ovulation, which indicates the establishment of
estrous cyclicity (Andrews, Mizejewski, & Ojeda, 1981).
Kisspeptin and its receptor GPR54 are critical for normal pubertal development
and fertility (Han et al., 2005; Irwig et al., 2004; Messager et al., 2005; Seminara et al.,
2003). Central administration of kisspeptin increases plasma lutenizing hormone (LH)
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and advances vaginal opening by approximately 4 days (Navarro et al., 2004). Blocking
kisspeptin signaling with a GnRH receptor antagonist, acycline, blocks LH secretion
(Shahab et al., 2005). Nearly 80% of GnRH neurons express GPR54 mRNA in adult rats,
mice and fish (Irwig et al., 2004), but adult levels of GRPR54 expression are reached
gradually. Approximately 40% of GnRH neurons express GPR54 pre-pubertally and
adult levels are reached peripubertally.
Estradiol and Maturing Neural Circuits.
The ability of estradiol to induce LH mini-surges does not appear until the 3rd
postnatal week, depending on housing conditions. LH mini-surges refer to an increase in
LH that is smaller than the pre-ovulatory surge seen at first proestrus. As females
approach the late phase of puberty the ability of estradiol to increase the frequency and
amplitude of GnRH/LH secretions increases (Urbanski HF and Ojeda SR, 1985). The
appearance of LH mini-surges during pubertal development is the result of higher levels
of ovarian estradiol (Urbanski, 1986). Ovariectomized pubertal females receiving a low
dose of estradiol (resembling late juvenile/early pubertal levels) show suppressed LH
levels (Urbanski, 1986). Intermediate doses of estradiol (about 30% higher of gonadally
intact matched controls), causes LH surges of intermediate magnitude (Urbanski, 1986).
However, a high dose of estradiol causes adult proestrus-like surges of LH in pubertal
aniamls (Urbanski, 1986). Therefore, very small changes in plasma estradiol can
transform LH release from a basal level to intermediate minisurges to a full adult-like LH
surge in pubertal mice (Urbanski, 1986). A core region of the neural circuitry involved in
the generation of the preovulatory GnRH/LH surge is the anteroventral periventricular
nucleus (AVPv). The postnatal upregulation of kisspeptin expression in the AVPv seems
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to be dependent on estradiol (Clarkson, Boon, Simpson, & Herbison, 2009). Ovariectomy
on P15 reduces kisppeptin levels, while estradiol treatment restores it back to control
levels if administered from P15-30 (Clarkson et al., 2009). A similar result is seen in
aromatase knock out (ArKO) female mice in which there is a nearly 3-fold reduction in
kisspeptin expression in the AVPv of ArKO adults compared to WT (Bakker, Pierman, &
González-Martínez, 2010). Overall, these data suggest that the neural circuitry regulating
estradiol’s positive feedback matures during puberty and it is dependent on ovarian
estradiol.
Estradiol Levels During Pubertal Development
The slow rise in gonadal steroids during pubertal development is important for
full maturation of the neural circuits involved in female reproduction (Bakker & Brock,
2010). During this time, the ovaries also undergo changes that allow them to respond to
changes occurring in the brain. The sensitivity of the ovary to gonadotropins increases
during pubertal development (Andrews et al., 1981; Ojeda SR, Urbanski HF, 1986). This
correlates with ovarian production of estradiol, which peaks during the days preceding
the first ovulation (Andrews et al., 1981). Part of this increased ovarian responsiveness to
gonadotropins is driven by a higher expression of LH and FSH receptors in the ovary
(Andrews et al., 1981). In addition, episodic exposure of the pubertal ovary to LH in vitro
is more efficient at inducing estradiol synthesis, compared to continuous LH exposure
(Urbanski HF and Ojeda SR, 1985). This suggests that the pubertal ovary is sensitive to
the pattern of LH secretion, which may be fundamental for the steroidogenesis leading to
the establishment of estrous cyclicity.
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Aromatase Enzyme
Aromatase is the enzyme responsible for estrogen biosynthesis. Aromatase
mRNA expression and aromatase enzyme activity in the ovary increases almost 7-9 fold
as animals approach puberty (Mannan & O’Shaughnessy, 1991; S A Gray, 1995).
Consistent with this, ovarian estradiol levels in female rats are low between P1-P14
(levels ranged from 2-13.0pg/ovary), but rise to 60pg/ovary by P30 (Galas et al., 2012).
Peripubertal ovaries incubated with androstenedione had an increased ability to release
estradiol as they approach puberty, the peak of secretion which was seen on P38 (Mannan
& O’Shaughnessy, 1988). This observation coincides with a concomitant reduction in
enzymes that metabolize steroids, like 5-alpha reductase (Mannan & O’Shaughnessy,
1988). In addition, pre-pubertal levels of circulating estrogens in females may be
negligible, because of the expression of alpha-fetoprotein. Serum levels of alphafetoprotein analyzed on P12, P16, P20, P24 and P28, showed that females had the highest
level of alpha-fetoprotein on P12, but these levels decrease sharply by P28 (puberty)
(Andrews et al., 1981). Overall, these data suggest that the ovaries show an enhanced
ability to secrete estradiol during the peripubertal period.
Puberty as a Sensitive Period
Puberty is a sensitive period for further remodeling of behavioral responsiveness
to steroids. Full expression of female sexual receptivity in adulthood depends on
peripubertal estradiol (Bakker, Honda, Harada, 2003). Aromatase knockout females
(ArKO) display low levels of hormone-induced sexual behavior in adulthood (Bakker,
Honda, Harada, 2003), but exposure to peripubertal estradiol rescues adult sexual
behavior. On the other hand, the same estradiol regimen has no effect if given pre-

6

pubertally (P5-15) (Brock, Baum, & Bakker, 2011). Similarly, male hamsters that
undergo puberty without exposure to gonadal hormones show deficits in adult
reproductive behavior (Schulz, Zehr, Salas-Ramirez, & Sisk, 2009). Testosterone
replacement during the peripubertal period rescues the full behavioral phenotype, but has
no effect if administered post-pubertally (Schulz et al., 2009). Together, these data
suggest that the timing and exposure of the brain to gonadal hormones are critical factors
driving the full maturation of the reproductive behavioral repertoire.
Brain Regions Critical for Female Reproduction
The anteroventral periventricular nucleus (AVPv), arcuate nucleus (Arc) and
ventromedial hypothalamus (VMH) are critical for appropriate function of female
reproduction. In addition, these brain regions express levels of estrogen receptors, and
undergo considerable functional remodeling during pubertal development. Therefore,
these brain regions are good model systems for studying the mechanisms by which
estradiol modulates microglia during the pubertal sensitive period.
The ventromedial nucleus of the hypothalamus (VMH) is a core region regulating
female sexual receptivity. The development of the behavioral responsiveness to hormoneinduced sexual behavior develops peripubertally. Pre-pubertal female guinea pigs do not
display lordosis in response to estradiol and progesterone treatments that normally elicit
sexual behavior in adults (Olster DH, 1989). The ability of estradiol and progesterone to
induce sexual receptivity increases as females develop. On P20, female guinea pigs do
not display lordosis. However, as animals transition into puberty, the ability of this
hormone regimen to induce increases gradually; on P30 ~25% of females display
lordosis, followed by a 50% on P40, 80% by P50 and nearly 100% in adulthood (Olster
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DH, 1989). The inability of immature females to show sexual receptivity may be in part
due to the fact that younger females show ~30% fewer estrogen receptor
immunoreactivity in the VMH compared to adult animals (Olster, 1994). Full expression
of female sexual receptivity is dependent on peripubertal estradiol (Brock et al., 2011).
Overall, these data suggest that the VMH undergoes significant functional remodeling
during pubertal development and estradiol may play a role in this maturational process.
The anteroventral periventricular region (AVPv) is integral component of the
neuroendocrine circuit underlying the generation of the pre-ovulatory luteinizing
hormone (LH) surge. The ability to ovulate is achieved during pubertal development,
although the establishment of the adult pattern of gonadotropin secretion is established
neonatally. Pre-pubertal females are unable to release a pre-ovulatory-like surge of LH in
response to estradiol (Olster, 1994), suggesting that this brain region undergoes
functional remodeling during puberty. The AVPv possesses a core population of
kisspeptin neurons, which is critical for pubertal maturational processes (Seminara et al.,
2003). Virtually all kisspeptin neurons express estrogen receptor alpha (Clarkson et al.,
2009), and estradiol increases the activity of kisspeptin neurons in the AVPv (Gottsch et
al., 2011). The number of kisspeptin-expressing cells increases gradually in the female
AVPv. At 3weeks old, animals have approximately 300 kisspeptin cells which increases
2-fold by 5 weeks of age (Takumi, Iijima, & Ozawa, 2011). This addition correlates with
the gradual increase in the amplitude and frequency of gonadotropin surges that occurs
peri-pubertally. Also, the AVPv is a sexually dimorphic region that is larger in females,
compared to males. However, the female AVPv does not increase in volume until puberty
(Davis CE, Shryne JE, Gorski RA, 1996), suggesting that pubertal processes contribute to
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adult sex differences in this nucleus. The increase in volume of this nucleus is due to the
addition of newly born cells, as measured by BrDU (Ahmed et al., 2008). Removing the
ovaries prior to pubertal onset abolishes the volume increase in the female AVPv, while
estradiol treatment rescues it (Ahmed et al., 2008). Overall, these data suggest that the
AVPv is functionally remodeled during puberty and that full maturation of this circuitry
is critical for the establishment of ovulation.
A second population of kisspeptin neurons is located in the arcuate nucleus
(ARC). While estradiol elevates kisspeptin mRNA in the AVPv, it suppresses it in the
ARC (Gottsch et al., 2011). Also, while the number of kisspeptin neurons increases in the
female AVPv , the number of kisspeptin cells in the ARC remains stable at 3, 4 and 5
weeks old when there are about approximately 300-600 neurons (Han et al., 2005;
Redmond et al., 2011; Takumi et al., 2011). This region was included in our analysis
because the ARC is a critical for the negative feedback system of the HPG axis
(hypothalamic-pituitary-gonadal), which seems to be fully operative before, during and
after puberty (Navarro et al., 2009). Nevertheless, the ARC undergoes architectural
changes during pubertal development. In the female ARC, about 35% of cells born
during pubertal development are either neurons or astrocytes, as quantified by duallabeling of BrdU and NeuN or GFAP. However, 65% of newly generated cells in the
ARC become functionally integrated into the hypothalamic network and have not been
profiled (Mohr & Sisk, 2013). These cells could include microglia and oligodendrocytes,
but this remains to be determined. Overall, these data suggest that the ARC undergoes
changes in its architecture by the addition of new cells that include neurons and
astrocytes, and potentially oligodendrocytes and/or microglia.
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The periventricular nucleus of the thalamus (pvThal)is a thalamic nucleus that
expresses low levels estrogen receptor (Mitra et al., 2003; Pérez, Chen, & Mufson, 2003;
Shughrue, Paul J, Scrimo P, Lane M, Askew R, 1997; Shughrue, Lane, & Merchenthaler,
1997). The pvThal receives distinct inputs from hypothalamic areas, particularly
hypothalamic peptides that are critical for arousal (Kirouac, 2015) (Colavito, Tesoriero,
Wirtu, Grassi-Zucconi, & Bentivoglio, 2015) (de Lecea, 2012). Arousal is a state of
wakefulness, increased locomotor activity and responsiveness to sensory inputs.
Anatomical evidence also suggests that the pvThal received information from neurons
involved in visceral or homeostatic functions (Kirouac, 2015). The pvThal projects to
limbic subcortical structures associated with motivated behavior like the nucleus
accumbens and amygdala (Colavito et al., 2015). Therefore, the pvThal represents a relay
station for the interaction between hypothalamic nuclei and autonomic sensory
processing, both of which are reorganized during inflammatory events. The pvThal does
not seem to be remodeled extensively during pubertal development. Experimental
evidence suggest that circuits performing lower-level, yet fundamental processes like
sensory processing areas, mature earlier in development compared to higher order
structures (Knudsen, 2004). In addition, because the pvThal expresses low levels of
estrogen receptors, it allows us to dissociate the interactions between estradiol and
microglia.
The Role of Microglia During Sensitive Periods of Development
Gonadal hormones affect pubertal maturational processes via mechanisms that
include cell death, synaptic pruning and cell genesis. Microglia are the resident-immune
cells of the brain, and they comprise approximately 15-20% of the total number of cells
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in the brain. In the mouse, microglial colonization begins on embryonic day 8 and it is
completed by the first few post-natal weeks (Alliot, Godin, & Pessac, 1999). After
colonization, microglia become the immunocompetent cells and perform functions
associated with innate and adaptive immunity (Schwarz, Sholar, & Bilbo, 2012). In the
adult brain, the entire parenchyma is filled with microglia that have clear and defined
territory, with no overlapping cells (Alliot et al., 1999; Lawson, Perry, Dri, & Gordon,
1990). Although typically associated with the immune response, microglia are also
involved in normal developmental processes.
The number of microglial cells may be associated with increased vulnerability to
neuroinflammation during critical developmental periods. Male mice have higher
numbers of microglia during the early postnatal period, compared to females (Schwarz et
al., 2012). An immune challenge during this period programs microglial reactivity longterm, and it affects biologically relevant behaviors like learning and memory (Bilbo et al.,
2005). On the other hand, female mice have higher numbers of microglial cells during
pubertal development and young adulthood in areas with high expression of estrogen
receptors (Schwarz et al., 2012).
In females, LPS administered during puberty decreases hormone-induced sexual
behavior in adulthood, but not when it is administered in other developmental periods.
Interestingly, removing the ovaries of pubertal animals prior to LPS treatment ‘protects’
females from the decrease in sexual behavior, meaning that ovariectomized females
receiving LPS show similar levels of hormone-induced behavioral receptivity as control
(saline treated) animals (unpublished observations, Rappleyea B). These data suggest that
ovarian secretions are a key factor in conferring vulnerability to LPS during puberty.
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Microglia express estrogen receptors (Sierra et al., 2008). It is unknown if steroids of
ovarian source are implicated in vulnerability to LPS during sensitive periods of
development.
Recently, microglia have been implicated in normal neurodevelopmental
processes during sensitive periods of development. In a set of experiments it was shown
that in the healthy brain, microglial ramifications contact neural synapses for elimination
via the complement system. The complement system is an arm of the innate immune
system that consists of a network of proteins that adhere to pathogens and coat them with
‘complement’ proteins, which serve as to “tag” pathogens for destruction by
macrophages (e.g. microglia) (Hong & Stevens, 2016). Key signaling molecules of the
classical complement pathway include C1q, C3 and CR3. An example of this involves
the retinogeniculate pathway. During the sensitive period for the formation of the
retinogeniculate pathway, neuronal immature synapses express C3 (Hong & Stevens,
2016). Microglia express CR3 (complement receptor), which activates the classical
complement signaling pathway. This then instructs microglia to engulf and eliminate
immature synapses (Stevens et al., 2007). Disruption of any of the key signaling
molecules in the classical complement pathway, like C1q, C3 or CR3 causes deficits in
synaptic connectivity (Hong & Stevens, 2016). The fractalkine (CX3CL1) pathway is
another mechanism by which the immune system sculpts the brain via synaptic pruning.
CX3CR1 is a chemokine receptor expressed by multiple immune cells including
monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells (Cardona
et al., 2006). In the brain, this chemokine receptor is exclusively expressed in microglia
and fractalkine is the only ligand for the CX3CR1 receptor (Cardona et al., 2006).
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CX3CR1 KO mice have abnormal microglial responses at baseline levels and after an
immune challenge. These data suggest that dysregulation of immune molecules in the
brain leads to neuronal cell death, resulting in altered neural circuits and behavioral
deficits (Hong & Stevens, 2016). Importantly, synaptic pruning controlled by aspects of
the immune system is down-regulated in mature mice, suggesting that there is an
enhanced involvement of the immune system during sensitive periods of development.
The Role of Microglia During Neuroinflammation
Neuroinflammation refers to the coordinated activation of the brain’s immune
system that enables it to respond to pathogens, injury and toxins. Basal or normal
immune signaling, such as the one characteristic of sensitive periods, differs from
neuroinflammation in that it lacks overt symptoms typically associated with sickness like
lethargy and/or overall alterations in motivational states which have been described for
acute and chronic neuroinflammation. Lipopolysaccharide (LPS) is commonly used to
study neuroinflammatory processes. LPS is a major component of the outer membrane of
gram-negative bacteria and it signals through its receptor, toll-like receptor 4 (TLR4).
When activated, TLR4 transduces intracellular signals involved in the induction of the
immune response. The TLR gene was originally discovered in Drosophila and was found
to be critical for development and patterning of the dorsal-ventral axis, as well as
immunity (Parnet, Kelley, Bluthe, & Dantzer, 2002). Furthermore, TLR4 seems to be
responsible for the brain’s innate immune response triggered by peripheral LPS
(Laflamme & Rivest, 2001). Data supporting the role of TLR4 in LPS signaling came
from TLR4 KO mice, which rendered these animals resistant to the effects of LPS
(Poltorak et al., 1998). In the brain parenchyma, TLR4 receptors are nearly exclusively
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expressed in microglial cells (Lehnardt et al., 2002). Interestingly, microglia undergo a
postnatal maturation process in TLR4 expression, particularly during puberty. In mice, a
window between postnatal days P21 and P49 is a particularly dynamic time where
microglia exhibit great changes in multiple genes critical for immune function (Scheffel
et al., 2012).
It is clear that peripheral inflammation, initiated by administration of
intraperitoneal LPS, is transduced to the brain. Very small amounts of LPS enter the brain
and cytokines are relatively large molecules that should not be able to cross the blood,
brain barrier (BBB). One way by which peripheral inflammation can be transduced to the
brain is via circumventricular organs (CVO). CVOs are brain structures with dense
vascularization but lacking a blood brain barrier (BBB). In these regions, the junctions
between endothelial cells are not as tight as in the rest of the BBB (Nguyen, Julien, &
Rivest, 2002). Three out of the four brain regions analyzed in this dissertation are near
CVOs. TLR4 is expressed in CVOs and some suggest that this is the core mechanism by
which peripheral LPS activates the innate immune response in the brain (Laflamme &
Rivest, 2001). Furthermore, the vascular organ of the lamina terminalis (OVLT)
possesses receptors for IL1, IL6, TNF-alpha (Laflamme & Rivest, 2001). CVOs include
the vascular organ of the lamina terminalis, the subfornical organ, the median eminence,
and the area postrema (Nguyen et al., 2002). The OVLT is particularly relevant in our
studies because of its vicinity to the preoptic area. Lesions to the OVLT block the fever
typically induced by peripheral LPS (Laflamme, Soucy, & Rivest, 2001). Cells located in
the OVLT are influenced by fever-inducing cytokines coming from the periphery, as
measured by changes in neuronal firing rates of thermosensitive neurons adjacent to the
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OVLT (Laflamme et al., 2001).
Microglial morphology is linked to its function. There is incredible microglial
morphological diversity among brain regions. This diversity is in part due to the signature
of the biochemical microenvironment in which microglia operate (Hong & Stevens,
2016; Olah, Biber, Vinet, & Boddeke, 2011). The highest density of microglia is found in
the telencephalon, followed by the diencephalon and rhombocephalon (Lawson, 1990). In
recent years, the traditional view that microglia transitions in a stereotypical manner from
a ramified phenotype to an activated amoeboid phenotype after immune activation has
been challenged. Microglia morphometric properties are usually reported as an average
profile, which results in loss of resolution of the diversity of morphological phenotypes
within a given region (Gertig & Hanisch, 2014). This strengthened the assumption that all
microglia within a given region have the same function, and that their effects are additive
(Gertig & Hanisch, 2014). However, more sensitive imaging techniques and analytical
approaches have revealed that microglia are highly dynamic and adopt meaningful
intermediate morphologies even within brain regions, which is supported by the present
work (Kettenmann, Hanisch, Noda, & Verkhratsky, 2011a).
Microglial diversity may be the result of their receptor expression profile
(Hanisch, 2013). It is unknown if microglia within a specific brain region can perform
multiple functions or if subsets of microglia have a bias for specific functions (Hanisch,
2013). Immune cells outside the brain are classified into categories like lymphocytes,
dendritic cells and macrophages, but there are subsets of specialized cells within those
categories based on their transcriptomes. It is possible that a single microglial cell is
capable of displaying all the functions that have been associated with microglia.
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Alternatively, microglial heterogeneity within a single brain region could be the result of
microglial specialization. For example, LPS increases microglial-derived TNF-alpha
levels within discrete brain regions. However, when resolved at the single cell level, only
a subpopulation of microglial cells secrete TNF-alpha (Gertig & Hanisch, 2014). Overall,
these data suggest that sub-populations of microglia within a brain region can have
specialized functions following immune activation. Microglial receptor profiles would be
helpful in identifying sub-populations of microglia. It is possible that microglia
expressing receptors for specific neuromodulators (e.g. estradiol), shift microglial cells
towards a specific functional phenotype (Gosselin et al., 2014; Hong & Stevens, 2016).
Detailed analysis of microglial morphometric properties is a useful tool to
understand their function (Karperien, Ahammer, & Jelinek, 2013) (Beynon & Walker,
2012). The most commonly used microglial markers are CD11b and Iba1 (Beynon &
Walker, 2012). However, CD11b is also expressed by peripheral neutrophils and
monocytes and these cells penetrate the brain after injury, making it difficult to
distinguish microglia from neutrophils and monocytes unless additional markers are used
(Kettenmann, Hanisch, Noda, & Verkhratsky, 2011b). This is important because it may
lead to the misconception that neutrophils and monocytes with a round shape are
“amoeboid” microglia. Iba1 on the on the other hand, is expressed by monocytes, but not
by neutrophils (Beynon & Walker, 2012). However, monocyte infiltration usually starts
48h post-injury (Jeong, Ji, Min, & Joe, 2013) and our microglia analyses occurred 24h
post-injection, which makes it unlikely that our Iba1 stained cells are infiltrated
monocytes.
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There are multiple ways to quantify microglial morphological changes. In the
present work we used three different approaches. We used the thresholding approach,
which captures global changes in Iba1 labeling (Beynon & Walker, 2012). The advantage
of this approach is that it captures global changes in Iba1 includes microglial cells at
different z-depths. Microglia have 3-dimensional morphological properties, and
ramifications extend in multiple directions. Therefore, this approach quantitates
microglial cell bodies and ramifications in our plane of view, but also primary and
secondary ramifications from microglial somata beyond our plane of view. Reporting
global changes in Iba1 staining (without further characterization of microglial
parameters) is common (Beynon & Walker, 2012). Although this is a useful measure for
determining global changes in microglial morphology, it does not characterize specific
morphometric changes of microglia (e.g. soma size, outgrowth, primary or secondary
bifurcations, etc). In order to understand the underlying basis of global changes in
microglial phenotypes, we used an approach that only analyzed microglia with cell bodies
in our plane of view and their associated ramifications. This allowed us to quantify the
number of microglia, microglial processes, branches, cell body size and overall
outgrowth. One of the advantages of this approach is that we can obtain the
morphometric properties of only microglial soma with primary processes in our plane of
view, while filtering out ramifications of microglial somata beyond our plane of view.
The limitation of this approach is that the quantification of changes in microglial
parameters are reported as an average profile. This results in the loss of resolution of the
diversity of microglia within a given region following LPS activation. This is an
important point to consider because it can strengthen the assumption that all microglia
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have the same function and that their effects are additive (Gertig & Hanisch, 2014). To
address this point, we analyzed microglial cell body to cell outgrowth ratio, which has
been validated (Hovens, Nyakas, & Schoemaker, 2014). In the microglial ratio spectrum,
a ratio between 0.00-1.00 reflects properties of highly ramified microglia (basal and/or
surveying microglia), whereas a 3.00+ ratio reflects activated microglia (large somata and
short or nearly non-existent processes, associated with a phagocytic stage. Ratio analysis
results serves as a basis to understand functional roles of microglia with divergent
morphologies in a given brain region.
Sickness Behavior
Organisms respond to infection with a common set of symptoms called sickness
behavior. Sickness is a conglomeration of non-specific symptoms mediated by the central
nervous system in response to immune activation. It involves a reorganization of the
motivational state of an organism that can be elicited by a myriad of pathogens. Sickness
can be induced by diverse microorganisms like bacteria, yeast and viruses despite a lack
of similarities between these types of pathogens (McCusker & Kelley, 2013). The
components of sickness behavior include anorexia, decreased locomotor activity,
decreased motivation, hyperalgesia and changes in thermoregulation. Regardless of
where the immune response is first activated, the final center regulating all of these
symptoms must converge in the brain. After pathogen recognition, cytokines are the first
critical step in the inflammatory response. Cytokines are small proteins released by
macrophages and dendritic cells. Although cytokines are associated with the induction of
specific sickness components, the reality is that there is a great deal of redundancy and
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these cytokines can act synergistically (Burgess W, Gheusi G., Yao J, Johnson RW,
Dantzer R, 1998).
Thermoregulation
Fever induction is a typical response to infection. However, hypothermia emerges
only during severe systemic inflammation (Romanovsky, Shido, Sakurada, Sugimoto, &
Nagasaka, 1996). Hypothermia is associated with decreased blood pressure, cold-seeking
behavior, and decreased metabolism (Romanovsky et al., 1996). The nadir for a
hypothermic response is approximately 1.5-3h post injection (Romanovsky et al., 1996).
The preoptic area is the core center regulating temperature. Peripheral administration of
LPS doses between 2.5mg/kg and 5mg/kg causes hypothermia approximately 2h post
injection, followed by a fever 6-8h post injection (Buttini & Boddeke, 1995). The
1.5mg/kg dose of LPS used in our studies is relatively high, but our experiments suggest
that estradiol amplify this response nearly 2-3 fold compared to oil-LPS treated animals.
TNF mRNA is present in the OVLT, AVPv and the median eminence on the floor of the
3rd ventricle as early as 1.5h through 3h post-LPS (Breder et al., 1994). At 6h post LPS a
small number of intensely labeled neurons are seen in ARC and lateral hypothalamic area
(Breder et al., 1994; Qin et al., 2007; Ulich, Guo, Irwin, Remick, & Davatelis, 1990).
This rapid initial peak of TNF alpha follows same time course as elevation of TNF in
plasma in rat (Breder et al., 1994). Overall, TNF-alpha seems to be the primary cytokine
driving hypothermia after immune activation by affecting the firing rate of
thermosensitive neurons located deep in the hypothalamus. On the other hand, LPSinduced fever is mediated by IL6. IL6 KO mice cannot mount a fever response following
LPS (Chai, Gatti, Toniatti, Poli, & Bartfai, 1996). Although IL-beta has been implicated
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in the fever response, it seems to be acting via IL6 (Chai et al., 1996). Intraperitoneal
injection of IL1 causes fever in WT animals, but IL1 is without effect in IL6 KO mice
(Chai et al., 1996). This suggests that the fever response induced by IL1 is caused by
downstream up-regulation of IL6 and signaling via the IL6 receptor (Chai et al., 1996).
Anorexia
Anorexia is part of the sickness repertoire. LPS causes body weight loss as a
result of decreased food intake (Iwasa et al., 2011). Anorexia during infection is due to
modulation of central neurochemical mechanisms that control normal eating. A crucial
cytokine mediating hunger suppression during infection is IL-1β. LPS is unable to induce
anorexia in IL-1β-converting enzyme KO mice, (Burgess W, Gheusi G., Yao J, Johnson
RW, Dantzer R, 1998). Evidence suggests that IL-1β mediates its effect partially by
acting on leptin, a peptide hormone that suppresses hunger (Sachot, Poole, & Luheshi,
2004). LPS increases leptin levels in a dose dependent manner (Nonaka, Hileman,
Shioda, Vo, & Banks, 2004). Neutralization of leptin post-LPS prevents the hormone
from binding to its receptor and blocks the effects of LPS on body weight (Sachot et al.,
2004). The ARC contains peptidergic neurons involved in feeding and has been
implicated in IL1 induced anorexia (Reyes & Sawchenko, 2002) (Nonaka et al., 2004).
The ARC expresses IL1 receptors (Ericsson, Liu, Hart, & Sawchenko, 1995; Quan,
Whiteside, & Herkenham, 1998) and IL1-beta injection induces cFos in ARC cells (Quan
et al., 1998; Reyes & Sawchenko, 2002). IL1 receptor antagonists abolish deficits in food
motivated behavior induced by LPS (Burgess W, Gheusi G., Yao J, Johnson RW,
Dantzer R, 1998). In the brain, the peak of IL1-beta mRNA expression occurs 6h post
peripheral LPS injection (Buttini & Boddeke, 1995). In a larger evolutionary context,
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suppressing hunger eliminates the need to search for food and redirects energy towards
fighting infection (Kanra, Özen, & Kara, 2006). With decreased food intake, there is less
availability of micronutrients like iron and zinc, which are essential for pathogen growth
(Kanra et al., 2006). Support for this notion comes from experiments that showed that
there is decreased survival time and increased mortality when rodents infected with the
bacteria Listeria are force-fed. Starved mice had 5% mortality rate after infection,
compared to 95% mortality rate of fed mice 24h post-infection (Kanra et al., 2006).
Overall, these data implicates IL1 in mediating the effects of LPS-induced anorexia by a
mechanism that involves leptin signaling in the ARC.
Lethargy
Lethargy is part of the sickness behavioral repertoire (Bonsall et al., 2015).
Lethargy minimizes energy expenditure which allows the organism to prioritize resources
to fight infection (Grossberg et al., 2011). The underlying neurobiology of inflammationinduced lethargy is not well characterized, but it is clear that reduced voluntary homecage locomotion is a hallmark of sickness. Several lines of evidence implicate IL1
signaling and orexin neurons in inflammation-induced lethargy (Grossberg et al., 2011).
Centrally and peripherally administered LPS (Gaykema RPA and Goehler, 2009) or IL1beta (Bonsall et al., 2015) reduce locomotor activity in a dose dependent manner.
Peripheral LPS administration increases IL1-beta mRNA and protein in the brain
(Burgess W, Gheusi G., Yao J, Johnson RW, Dantzer R, 1998) (Gabellec, Griffais,
Fillion, & Haour, 1995). IL1 signaling is necessary for the induction of lethargy by LPS
(Grossberg et al., 2011). IL1-beta receptor antagonists prevent LPS-induced reduction in
locomotion (Grossberg et al., 2011). IL1-beta neutralizing antibody attenuates the
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reduction in wheel-running activity caused by peripheral administration of IL1-beta
(Bonsall et al., 2015). Importantly, specific doses of IL1-beta are able to induce
decreased locomotion without causing the full induction of sickness behaviors (Bonsall et
al., 2015). IL1 receptors are expressed at high density in the endothelial cells of brain
venules, the preoptic and supraoptic areas of hypothalamus and subfornical organ
(Gabellec et al., 1995)(Laflamme et al., 2001). IL1 seems to exert its actions on
locomotion by influencing orexin neurons. In non-inflammatory scenarios, the orexin
network regulates behavioral arousal, which refers to increased alertness, wakefulness
and locomotion (Gaykema RPA and Goehler, 2009). Orexin treatment increases
behavioral arousal, orexin receptor antagonists decrease behavioral arousal (BrisbareRoch et al., 2007) and orexin KO mice have reduced running-wheel activity (Grossberg
et al., 2011). Orexin cells become activated as animals transition into the dark, which is
when they become behaviorally active (Gaykema RPA and Goehler, 2009). However,
peripheral LPS administration during this time reduces orexin neuronal activation nearly
6-fold, as measured by cFos (Gaykema RPA and Goehler, 2009). Intracerebroventricular
administration of orexin blocks the onset of LPS-induced lethargy (Grossberg et al.,
2011). The LPS-driven reduction in orexin activation causes a reduction in home-cage
locomotion (Gaykema RPA and Goehler, 2009). Orexin neurons do not seem to be direct
targets of inflammatory signaling since there is no co-localization of IL1 mRNA in
orexin neurons (Grossberg et al., 2011). This suggests that the effects LPS-induced
inhibitory input to orexin neurons is mediated by a nearby population of cells that are
sensitive to inflammation, which could include microglia. Overall, these suggest that the
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functional inhibition of the orexin network as a result of an immune challenge may
mediate LPS-induced lethargy.
Summary
Lipopolysaccharide (LPS) decreases hormone-induced female sexual behavior
only if it is administered during puberty. Consistent with this observation, pubertal
microglia react more strongly to LPS, compared to adult females receiving the same
treatment. Removing the ovaries prior to administering LPS protects pubertal females
from alterations in the behavioral response to hormones in adulthood. This suggests that
the ovaries are a key factor conferring vulnerability to LPS. Microglia express estrogen
receptors but it is unknown if estradiol regulates microglial reactivity during the pubertal
sensitive period. Therefore, the work presented in this dissertation was designed to test
the hypothesis that estradiol confers vulnerability to LPS by quantifying: (1) microglial
reactivity, (2) levels of pro-inflammatory cytokines, and (3) sickness behaviors, which
are controlled by the central nervous system like thermoregulation, food intake and
locomotor activity. We manipulated the hormone environment by using 3 approaches: (a)
ovarian presence or absence (Chapter 2), (b) estradiol replacement or oil vehicle
treatment (Chapter 4), and (c) administration of an aromatase inhibitor or vehicle
(Chapter 5). The present work suggests that estradiol enhances immune surveillance
during the pubertal sensitive period. However, over-activation of the immune system
results in a severe immune response, which can be permanently reorganized circuits
undergoing maturation. This work adds to the mounting evidence involving microglia in
normal developmental processes, particularly how estradiol enhances immune
surveillance during sensitive periods of development. Understanding the interaction
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between the endocrine, immune and central nervous systems in females may shed light
into factors that promote a sex bias in the prevalence of mood and immune-related
disorders, whose onset and progression in females emerge during the reproductive years.
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CHAPTER 2
OVARIAN SECRETIONS ENHANCE NEUROINFLAMMATION DURING
PUBERTAL DEVELOPMENT IN FEMALE MICE
Introduction
The endocrine system is a powerful regulator of the immune response (GottfriedBlackmore, Sierra, Jellinck, McEwen, & Bulloch, 2008). Steroid hormones are a family
of signaling molecules derived from cholesterol. The ovaries are one of the main sources
of estrogens and progestagens. These hormones can regulate the immune response, as
evidenced by the expression of receptors for each of these hormones in immune cells. In
females, the estrogen receptor is expressed in all cell types involved in the inflammatory
process including macrophages (e.g. microglia) (Cutolo et al., 1996), dendritic cells
(Mao, Paharkova-Vatchkova, Hardy, Miller, & Kovats, 2005), and T-lymphocytes
(Cohen, Danel, Cordier, Saez, & Revillard, 1983). This is important, because sex
hormones are thought to contribute to the sex bias in the incidence of auto-immune and
inflammatory diseases in women (Straub, 2007).
Microglia are the resident immune cells of the brain, and they express steroid
receptors (Gyoneva et al., 2014). Steroid hormones, like estradiol, can influence the
immune response by orchestrating the onset, amplitude, and duration of the inflammatory
response. Estradiol can do this by increasing the number of microglia, by modulating the
receptors expressed by microglia, by influencing their transcriptional profile, and by
affecting parameters of microglial morphology, thereby impacting microglial scavenging
functions. Estradiol treatment to ovariectomized female mice increases the reactivity of
basal microglia, while an aromatase inhibitor decreases it (Chapters 3 and 4). In addition,
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in gonadally intact females, LPS causes a robust innate immune response, while
ovariectomy attenuates it (Soucy, Boivin, Labrie, & Rivest, 2005). LPS is a useful tool to
trigger the signaling cascade associated with innate immunity (Nguyen et al., 2002). LPS
injected systemically or centrally triggers pro-inflammatory signaling cascades in
microglial cells throughout the brain (Nguyen et al., 2002). The main role of this rapid
inflammatory response is to eliminate pathogens and prepare the transition from innate to
adaptive immunity (Soucy et al., 2005).
Pubertal development is emerging as a sensitive period during which particular
stressors can reorganize brain circuits permanently (Green & McCormick, 2013) (Avital
& Richter-Levin, 2005) (Blaustein & Ismail, 2013). LPS decreases hormone-induced
sexual behavior in adulthood when administered during puberty, but not when it is
administered in other developmental periods. Interestingly, removing the ovaries of
pubertal animals prior to LPS treatment ‘protects’ females from the decrease in hormoneinduced sexual behavior. That is, ovariectomized females receiving LPS show similar
levels of behavioral receptivity as control (saline treated) animals (unpublished
observations, Rappleyea B). Together, these data suggest that ovarian secretions are a key
factor in conferring vulnerability to these long-term effects of LPS during puberty on
hormone response in adulthood.
Microglia display higher numbers of active phenotypes during sensitive periods of
development (Amateau & McCarthy, 2004; Bilbo & Schwarz, 2009; Lenz, Nugent,
Haliyur, & McCarthy, 2013). This is in part because microglia are involved in sculpting
neural circuits by supporting functions related to synaptic pruning and phagocytosis
(Paolicelli et al., 2011). Basal microglia monitor the microenvironment, and they are
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particularly active during periods of high synaptic turnover, maturation and elimination
(Paolicelli et al., 2011). During sensitive periods, microglial ramifications contact neural
synapses for elimination via the complement system. The complement system is an arm
of the innate immune system that consists of a network of proteins that adhere to
pathogens and coat them with ‘complement’ proteins, which serve as to “tag” pathogens
for destruction by macrophages (e.g. microglia) (Hong & Stevens, 2016). Key signaling
molecules of the classical complement pathway include C1q, C3 and CR3. Microglia
express CR3 (complement receptor), which activates the classical complement signaling
pathway. This then instructs microglia to engulf and eliminate immature synapses
(Stevens et al., 2007). Disruption of any of the key signaling molecules in the classical
complement pathway, like C1q, C3 or CR3 causes alterations in the establishment of
neural circuits (Hong & Stevens, 2016).
Interestingly, pubertal females show higher microglial reactivity to LPS in
hypothalamic nuclei involved in reproduction, compared to adult females receiving the
same treatment (Holder & Blaustein, 2017). Higher microglial reactivity in pubertal
animals is in part due to a higher number of hyper-ramified microglia in gonadally intact
pubertal, compared to adult controls (Holder & Blaustein, 2017). Overall, these data
suggest that puberty is a sensitive period in development during which microglia play a
critical role in the establishment and stability of neuronal circuits.
One of the hallmarks of puberty is the maturation of the reproductive axis, which
results in the secretion of gonadal steroid hormones. In turn, gonadal steroid secretions
impact neurobiological processes regulating reproduction at the molecular, cellular,
physiological and behavioral levels. We designed the following experiments to test the

27

hypothesis that ovarian estradiol enhance LPS-induced neuroinflammation in pubertal
female mice. We determined the effects of ovarian estradiol in sham-ovariectomized,
ovariectomized and gonadally intact females and quantified changes in the morphometric
properties of microglia. We measured microglial reactivity in brain regions that regulate
female reproduction, show a high density of estrogen receptors and undergo considerable
architectural changes during puberty like the ventromedial nucleus of the hypothalamus
(VMH), the anteroventral periventricular region (AVPv), the arcuate nucleus (Arc). We
also analyzed the periventricular nucleus of the thalamus, a thalamic nucleus that that
shows low expression of estrogen receptors (Pérez et al., 2003), but that is involved in
processing information from the autonomic nervous system (Kirouac, 2015). In addition,
we examined the effects of ovarian estradiol on plasma levels IL1-alpha, IL1-beta, IL6,
IL10 and TNF-alpha protein levels. Lastly, we determined the effects of ovarian estradiol
on the immune response by measuring changes in behavior (lethargy), physiology
(thermoregulation) and metabolism (body weight), which are critical components of
sickness and constitute an organized response to infection (Dantzer, 2001).
Experimental Design
Experiment 1: Do ovarian secretions modulate microglial reactivity?
Animals. Forty C57Bl/6 female mice arrived on postnatal day (P) 21 and were kept in a
14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad libitum food
and water. All procedures were performed according to the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and approved by the Institutional
Animal Care and Use Committee.
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Experimental Timeline. Animals underwent sham-ovariectomy or ovariectomy on P35. A
week later, on P42, animals received an intraperitoneal injection of LPS (1.5mg/kg) or
sterile saline within an hour prior to the onset of the dark phase of the light:dark cycle.
Brains were collected 24 hours post-injection.
Experiment 2: Do ovarian secretions modulate the cytokine response?
Animals. Forty-eight C57Bl/6 female mice arrived on postnatal day (P) 21 and were kept
in a 14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad libitum
food and water. All procedures were performed according to the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee.
Experimental Timeline. Animals underwent sham-ovariectomy or ovariectomy on P35. A
week later, on P42, animals received an intraperitoneal injection of LPS (1.5mg/kg) or
sterile saline within an hour prior to the onset of the dark phase of the light:dark cycle.
Brains were collected at 6h and 24h post-injection.
Methods
Ovariectomy. Animals were anesthetized on postnatal day P35 with isofluorane
(3% at one l/min, inhaled) and a single incision was made to the dorsal skin and the
muscle layer to locate the uterine horns. Once identified, the uterine horns were clamped,
the ovaries were removed, and the tips of the uterine horns were cauterized with an AcuCautery (Acuderm Inc, Fort Lauderdale, FL). The muscle layer was sutured with an
absorbable suture (Catalog# J315; Ethicon, PR), and the incision was closed using
surgical wound clips (Cat# 427631; Becton Dickinson, Sparks, MD). Shamovariectomized mice underwent all of these procedures but the ovaries were left intact.
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Mice were transferred to a heating pad to recover until they were fully awake and were
returned to their home cage. Gonadally intact females were left in the colony room for the
duration of the experiment.
E-mitter implant. We measured locomotor activity and core body temperature by
implanting a G2 E-mitter device (E-mitter Respironics Mini-mitter, Bend, OR) in the
abdominal cavity of mice on P35. The E-mitter was sutured to the abdominal muscle wall
to keep its placement stable. Prior to implantation, the E-mitter was washed with
Tergazyme, a detergent with protease enzyme activity. Following Tergazyme, E-mitters
were incubated in 3% glutaraldehyde to disinfect and sterilize the E-mitter, and rinsed
with sterile saline at least 3 times. Radio signals for locomotion and temperature were
recorded by a receiver board (ER-4000 energizer receiver) underneath the cage housing
each animal and stored via Vital View Data Acquisition System (version 4.1; Mini
Mitter) on a personal computer. Data were collected in 2-min bins. The mice were
allowed to recover from E-mitter implant surgery for at least 1 wk before onset of the
experiments.
Immunocytochemistry for Iba1. Brains were collected and fixed in 4%
paraformaldehyde for 24 hours, followed by an incubation in 30% sucrose in 0.1M PBS
for at least 72 hours. Brains were sectioned coronally in 30µm thick sections using a
cryostat. Free-floating sections were rinsed for 3×5 min in 0.05M tris-buffered saline
(TBS) and also rinsed before each subsequent step, except between the blocking and
primary antibody steps. Brain sections were quenched in 30% hydrogen peroxide and
blocked in 20% normal goat serum. Sections were then incubated for 48 hours at 4°C in
primary antibody (Iba1) mixed in gel TBS. After 48 hours, sections were incubated for 90
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mins at room temperature in a solution of biotinylated secondary antibody in gel TBS.
The Avidin-Biotin Complex (ABC) was used to bind a complex of streptavidin-biotin
peroxidase to the secondary antibody for 90 mins. The reaction was then developed with
diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA, USA) for 20 mins to
produce a colorimetric stain. Sections were mounted on gelatin-coated slides, dehydrated
and coverslipped with Polymount (Polysciences, Inc. Warrington, PA).
Microscopic analysis of Iba. Three photomicrographs of carefully matched
sections of the anteroventral periventricular area (AVPv), ventromedial nucleus of the
hypothalamus (VMH), arcuate nucleus (ARC) and periventricular thalamus (pvThal)
were taken from each animal using a Nikon Optiphot-2 microscope connected to a
QImaging Micropublisher RTV 5.0 digital color camera (Surrey, BC, Canada). Overall
Iba1 staining was quantified in the AVPv, ARC, VMH and Thal using the ImageJ
software (NIH Image, Scion Image). Images were converted to grayscale and thresholded
using the Max Entropy function in ImageJ. We quantified mean Iba1 staining, which
included microglial cells in our plane of view, as well as processes of microglial cell
bodies out of our plane of view. This is a widely used approach to quantify Iba1
immunoreactivity (Beynon & Walker, 2012) (Cherry, Olschowka, & O’Banion, 2015).
Morphometric analysis of individual microglia was quantified using the Metamorph
Neurite Outgrowth program (Molecular Devices, West Chester, PA, USA; version 7.7).
Using the Neurite Outgrowth software, we measured specific parameters of microglial
morphology that included total cell body size, mean cell body area, total outgrowth, mean
outgrowth, total branches, total processes and total number of microglia.
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Plasma. Trunk blood was collected into an EDTA (ethylenediaminetetraacetic
acid) treated tube (BD Vacutainer, Catalog #367842) and placed on ice. Blood was
centrifuged at 4°C in a microcentrifuge (Eppendorf 5415R). After centrifugation, plasma
was aliquoted and stored in -80°C freezer until assayed.
Statistics
To examine the effect of treatment (saline and LPS) and reproductive state (shamovariectomy or ovariectomy) on microglial morphology and body weight we used a twoway ANOVA and corrected for multiple comparisons using Bonferroni corrections.
Results
Ovarian secretions accelerate microglial activation in the VMH.
In the VMH, ovarian estradiol accelerates microglial activation. Ovarian estradiol
does not influence overall microglial reactivity (Fig. 2A) or cell body area (Fig. 2C-D)
following LPS. However, a closer examination reveals that ovarian estradiol increased
the number of microglia (Fig. 2B) and the number of processes (Fig. 2G), while
decreasing the number of microglial branches (Fig. 2H) in LPS treated females (an effect
that is not seen in ovariectomized females). This suggests that in LPS treated females,
ovarian secretions either enhance or accelerate the ability of microglia to become
activated cells. There is a decrease in the total number of microglial branches (Fig. 2H),
with a concomitant increase in the total number of processes (Fig. 2G) only in shamovariectomized females, which is stereotypical of highly ramified microglia thickening
their main microglial processes, while eliminating the secondary branches coming off the
main processes. This notion is further supported by the fact that there are more activated
microglia cells in females with intact ovaries at the time of LPS, compared to
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ovariectomized animals, although both groups had similar levels of basal or ‘surveying’
microglia (Fig. 3).
Ovarian estradiol accelerates microglial activation in the AVPv.
In the AVPv, ovarian secretions accelerate microglial activation. Ovarian
secretions increase microglial density (Fig. 5A), which is mainly driven by an increase in
microglial cell body (Fig. 5C). In addition, there are more activated microglia in females
that had their ovaries at the time of LPS. This effect is blocked by removal of the ovaries
(Fig. 6).
Ovarian estradiol accelerates microglial activation in the ARC.
In the ARC, ovarian estradiol accelerates microglial activation. Ovarian estradiol
enhances the ability of microglial cells of becoming activated by influencing microglial
outgrowth (Fig. 8E-H). Furthermore, there is a reduction in the total number of basal or
‘surveying’ microglia between sham-ovariectomized and ovariectomized females (Fig.
9). However, females that had ovaries at the time of LPS showed nearly a ~2-fold
increase in activated microglia, which is blocked or delayed in ovariectomized females
(Fig. 9).
Ovarian estradiol increases microglial reactivity to LPS in the Thal.
In the Thal, ovarian estradiol increases microglial reactivity to LPS. This
microglial reactivity is the result of the microglial outgrowth (Fig. 11E). Animals that had
ovaries at the time of LPS showed increased number of processes (Fig. 11G) and
increased secondary branches (Fig. 11H), which is not seen in ovariectomized females.
Interestingly, in sham-ovariectomy females, LPS increases the number of activated
microglia (ratio 3.00+) without affecting the number of basal microglia (ratio 0.00-1.99).
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LPS causes hypothermia in the presence of ovarian estradiol.
LPS causes hypothermia in the presence of ovarian estradiol. However, removal
of the ovaries attenuates the hypothermic response (Fig. 13). Interestingly, although LPS
induces fever, the hormone environment does not influence its amplitude, the time of
induction or its duration (Fig. 13). This is an important point because, although fever is a
stereotypical response to infection, hypothermia occurs only in severe cases of
inflammation. This suggests that ovarian secretions enhance inflammation in pubertal
female mice. Lethargy is another component of sickness and as expected, LPS reduced
locomotion (Fig. 14). Importantly, the hormone environment did not influence the
duration of the decrease in locomotion or the robustness of the effect (Fig. 14). Lastly,
LPS decreased the body weight in both sham-ovariectomized and ovariectomized females
(Fig. 15; Fig. 16). However, females that had ovaries at the time of LPS showed a greater
decrease in body weight compared to ovariectomized females 24h post injection (Fig.
16).
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Figure 2.1 Representative photomicrographs of microglia in the ventromedial
hypothalamus (VMH) of gonadally intact, sham-ovariectomized or ovariectomized
pubertal mice. A) Gonadally intact females. B) Sham-ovariectomized females treated
with saline. C) Sham-ovariectomized females treated with LPS. D) Ovariectomized
females treated with saline. E) Ovariectomized females treated with LPS.
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Figure 2.2. The effects of LPS on microglia in the ventromedial hypothalamus (VMH) of
gonadally intact, sham-ovariectomized or ovariectomized pubertal mice (mean ± SEM).
A) Microglial density. B) Number of microglia. C) Total cell body area. D) Mean cell
body area. E) Total outgrowth. F) Mean outgrowth. G) Total number of processes. H)
Total number of branches.
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Figure 2.3. Microglial heterogeneity in the ventromedial hypothalamus (VMH) of
gonadally intact, sham-ovariectomized or ovariectomized pubertal mice (mean ± SEM).
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Figure 2.4. Representative photomicrographs of microglia in the anteroventral
periventricular area (AVPv) of gonadally intact, sham-ovariectomized or ovariectomized
pubertal mice. A) Gonadally intact females. B) Sham-ovariectomized females treated
with saline. C) Sham-ovariectomized females treated with LPS. D) Ovariectomized
females treated with saline. E) Ovariectomized females treated with LPS.
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Figure 2.5. The effects of lipopolysaccharide on microglia in the anteroventral
periventricular area (AVPv) of pubertal mice that were sham-ovariectomized or
ovariectomized (mean ± SEM). A) Microglial density. B) Number of microglia. C) Total
cell body area. D) Mean cell body area. E) Total outgrowth. F) Mean outgrowth. G) Total
number of processes. H) Total number of branches.
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Figure 2.6. Microglial heterogeneity in the anteroventral periventricular area (AVPv) of
gonadally intact, sham-ovariectomized or ovariectomized pubertal mice (mean ± SEM).
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Figure 2.7. Representative photomicrographs of microglia in the arcuate nucleus (Arc) of
gonadally intact, sham-ovariectomized or ovariectomized pubertal mice. A) Gonadally
intact females. B) Sham-ovariectomized females treated with saline. C) Shamovariectomized females treated with LPS. D) Ovariectomized females treated with saline.
E) Ovariectomized females treated with LPS.
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Figure 2.8. The effects of lipopolysaccharide on microglia in the arcuate nucleus (ARC)
of pubertal mice that were sham-ovariectomized or ovariectomized (mean ± SEM). A)
Microglial density. B) Number of microglia. C) Total cell body area. D) Mean cell body
area. E) Total outgrowth. F) Mean outgrowth. G) Total number of processes. H) Total
number of branches.
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Figure 2.9. Microglial heterogeneity in the arcuate nucleus (ARC) of pubertal mice that
were sham-ovariectomized or ovariectomized a week prior to saline or LPS injection
(mean ± SEM).
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Figure 2.10. Representative photomicrographs of microglia in the thalamus (Thal) of
gonadally intact, sham-ovariectomized or ovariectomized pubertal mice. A) Gonadally
intact females. B) Sham-ovariectomized females treated with saline. C) Shamovariectomized females treated with LPS. D) Ovariectomized females treated with saline.
E) Ovariectomized females treated with LPS.
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Figure 2.11. The effects of lipopolysaccharide on microglia in the thalamus (Thal) of
pubertal mice that were sham-ovariectomized or ovariectomized (mean ± SEM). A)
Microglial density. B) Number of microglia. C) Total cell body area. D) Mean cell body
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Figure 2.13. The effects of lipopolysaccharide on temperature of sham-ovariectomized or
ovariectomized pubertal mice a 24h time frame post saline or LPS injection (mean ±
SEM).
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ovariectomized pubertal mice a 24h time frame post saline or LPS injection (mean ±
SEM).

47

saline

****

****

sham ovariectomy

ovariectomy

6

Body weight change (%)

LPS

4
2
0
-2
-4
-6
-8
-10

Reproductive state
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Discussion
One of the hallmarks of puberty is the maturation of the reproductive axis, which
results in the secretion of gonadal steroid hormones. In turn, gonadal steroid secretions
impact neurobiological processes regulating reproduction at the molecular, cellular,
physiological and behavioral levels. We designed these experiments to test the hypothesis
that ovarian secretions enhance LPS-induced neuroinflammation in female mice. We
determined the effects of the ovarian secretions on microglia, cytokines and physiological
changes associated with sickness behavior. This work is important because pubertal
development is a sensitive period during which an immune challenge can alter brain
circuits permanently (Avital & Richter-Levin, 2005) (Blaustein & Ismail, 2013).
Our data suggest that ovarian secretions, possibly estradiol, enhance LPS-induced
inflammation in pubertal mice. However, estradiol is generally thought to have antiinflammatory properties. This is based on robust data that show that estradiol inhibits
inflammation by acting on multiple steps of the inflammatory cascade. For example, LPS
activates microglia and induces monocyte recruitment in the cerebral cortex and
hippocampus, and estradiol attenuates this increase by ~70% (Vegeto et al., 2006).
Ovariectomy accelerates the appearance of highly reactive microglia and this is reversed
by estradiol (Vegeto et al., 2006). Also, estradiol blocks the LPS-driven increase in iNOS
(Bruce-Keller et al., 2000), and attenuates the induction of IL1 and IL6 (Brown,
Mulcahey, Filipek, & Wise, 2010). The common thread among the studies reporting antiinflammatory effects of estradiol on microglia is that they measure inflammatory
outcomes in cortical regions and/or in the aging brain. Age is a critical factor in
determining the effects of estradiol. Aging mice have an exaggerated immune response to
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LPS, compared to younger animals (Godbout et al., 2005). Aging mice show at least a 4fold induction in IL6 and IL1 protein levels in the whole brain following LPS. The
induction of IL6 and IL1 in LPS treated females is twice as much in older animals,
compared to young mice (Godbout et al., 2005). In addition, LPS increases IL1 levels in
the pituitary gland in both young and senescent animals. However, estradiol attenuates
IL1 expression only in senescent animals (Johnson, Bake, Lewis, & Sohrabji, 2006)
(Godbout et al., 2005). Overall, these data suggest that age and the brain
microenvironment are powerful determinants of the effects of ovarian secretions on
neuroinflammation.
Ovarian secretions confer vulnerability to LPS in pubertal females (unpublished
observations; Rappleyea B). Pubertal exposure to a single injection of LPS remodels the
brain circuitry regulating reproductive behavior (Ismail, Garas, & Blaustein, 2011;
Laroche, Gasbarro, Herman, & Blaustein, 2009). The reduction in hormone-induced
sexual receptivity seen in LPS treated animals is in part due to a decrease in ERexpressing cells in brain regions regulating reproductive behavior (Ismail et al., 2011).
Gonadally intact pubertal females show higher basal microglial reactivity and pubertal
microglia react more strongly to LPS, compared to adults (Holder & Blaustein, 2017).
Together, these data supports the notion that puberty is a sensitive period during which an
inflammatory insult can permanently alter brain circuits.
Ovarian estradiol is essential for mounting an appropriate immune response to
LPS (Soucy et al., 2005). In addition to factors like reproductive status or brain
microenvironment, estradiol can have anti-inflammatory or pro-inflammatory effects on
the immune response based on the concentration of the hormone (Gottfried-Blackmore et
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al., 2008). In vitro, LPS induces phagocytic activity in microglial cells, as measured by
fluorescent bead uptake by microglia (Bruce-Keller et al., 2000). Medium-doses of
estradiol block microglial phagocytic activity close to saline-treated cells. However, low
and high doses of estradiol have no effect on microglial phagocytic activity, which means
that they show similar levels of phagocytosis as hormone-deprived LPS cells (BruceKeller et al., 2000). There are no comprehensive reports of estradiol levels or the pattern
of estradiol secretion during pubertal development. However, we have a relatively good
understanding of the neural circuitry regulating the gonadotropin secretions during
puberty in female mice. Electrophysiological, pharmacological and
transcriptional/protein data on kisspeptin and its receptor GPR54, suggest that there is a
gradual increase in the pulsatility of gonadotropins during the peripubertal period, and
this matches gonadotropin levels in circulation (Navarro et al., 2004; Shahab et al., 2005).
This suggests that estradiol may increase gradually in pubertal animals. Vaginal opening,
which is a widely used external indicator of puberty onset, is dependent on estradiol
secretion.
There is a dynamic interaction between the immune, endocrine, and central
nervous systems. Fertility is regulated by the hypothalamus-pituitary-gonadal axis and
this system is conserved across species including human, chimp, mouse rat and sheep
(Kaiser & Kuohung, 2005). The present data suggest that microglia are more reactive
during pubertal development and that ovarian secretions may be playing an important
role in brain regions that undergo significant remodeling during this period.
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CHAPTER 3
ESTRADIOL ENHANCES NEUROINFLAMMATION DURING PUBERTAL
DEVELOPMENT IN FEMALE MICE
Introduction
Sensitive periods of development are time windows during which the effects of
experience are unusually strong (Knudsen, 2004). Pubertal development is emerging as a
sensitive period, and particular stressors during this time can reorganize brain circuits
permanently (Green & McCormick, 2013) (Avital & Richter-Levin, 2005) (Blaustein &
Ismail, 2013). One of the hallmarks of puberty is the maturation of the reproductive axis,
which results in the secretion of gonadal steroid hormones. In turn, gonadal steroid
secretions impact neurobiological processes regulating reproduction at the molecular,
cellular, physiological and behavioral levels.
Puberty is a sensitive period for further remodeling of behavioral responsiveness to
steroids. Male hamsters that undergo puberty without exposure to gonadal hormones
show deficits in adult reproductive behavior (Schulz et al., 2009). Testosterone
replacement during the peripubertal period rescues the full behavioral phenotype, but has
no effect if testosterone is given post-pubertally (Schulz et al., 2009). Similarly, full
expression of female sexual receptivity in adulthood depends on peripubertal estradiol
(Bakker, Honda, Harada, 2003). Aromatase knockout females (ArKO) display low levels
of hormone-induced sexual behavior in adulthood (Bakker, Honda, Harada, 2003), but
exposure to peripubertal estradiol rescues adult sexual behavior. On the other hand, the
same estradiol treatment has no effect if given pre-pubertally (PD 5-15) (Brock et al.,
2011). Together, these data suggest that the timing and exposure of the brain to gonadal
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hormones are critical factors driving the full maturation of the reproductive behavioral
repertoire.
Gonadal hormones affect pubertal maturational processes via mechanisms that
include cell death, synaptic pruning and cell genesis. Estradiol increases the number of
new cells generated in the AVPv during puberty. Peripubertal ovariectomy blocks cell
genesis and estradiol treatment rescues it, suggesting that estradiol of ovarian origin is
driving cell genesis (Ahmed et al., 2008). In brain regions that contain high density of
estrogen receptors, approximately 27% of cells born during puberty are either neurons or
astrocytes, as quantified by dual-labeling of BrdU and NeuN or GFAP (Mohr & Sisk,
2013). For example, in the arcuate nucleus, 35% of new cells are either neurons or
astrocytes, while in the medial preoptic area only 20% are (Mohr & Sisk, 2013). On the
other hand, >60% of cells born during puberty have not been profiled and could include
microglia (Mohr & Sisk, 2013).
Microglia are the resident-immune cells of the brain, and they secrete immune
molecules that are crucial for normal developmental processes (Bilbo & Schwarz, 2009).
However, during sensitive periods of development an inflammatory insult can remodel
neural circuits permanently (Bilbo & Schwarz, 2012). Microglia express estrogen
receptors (Sierra et al., 2008), which suggests that estradiol can modulate the onset,
duration and/or culmination of neuroinflammation. Lipopolysaccharide (LPS) is a core
component of the outer membrane of gram-negative bacteria. A single injection of LPS
induces a robust immune response and activates a strong inflammatory cascade.
Interestingly, pubertal females show stronger microglial activation in hypothalamic areas
associated with reproduction, compared to adult females receiving the same LPS
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treatment (Holder & Blaustein, 2017). Furthermore, LPS-driven neuroinflammation
decreases hormone-induced adult sexual behavior in mice when administered during
puberty, but not when it is administered in other developmental periods (Laroche et al.,
2009) (Ismail et al., 2011). Interestingly, removing the ovaries of pubertal animals prior
to LPS treatment ‘protects’ females from the decrease in sexual behavior, suggesting that
the ovarian secretions are a key factor conferring vulnerability to LPS during puberty
(Rappleyea B., unpublished observations).
We designed the following experiments to test the hypothesis that estradiol
enhances inflammation during pubertal development in female mice. We determined the
effects of estradiol replacement or oil vehicle in ovariectomized females and quantified
changes in the morphometric properties of microglia. We measured microglial reactivity
in brain regions that regulate female reproduction, show a high density of estrogen
receptors and undergo considerable architectural changes during puberty like the
ventromedial nucleus of the hypothalamus (VMH), the anteroventral periventricular
region (AVPv), the arcuate nucleus (Arc). We also analyzed the periventricular nucleus
of the thalamus (pvThal), a thalamic nucleus that that expresses low levels of estrogen
receptors (Pérez et al., 2003), but that is involved in processing information from the
autonomic nervous system (Kirouac, 2015). In addition, we examined the effects of LPS
on IL1-alpha, IL1-beta, IL6, IL10 and TNF-alpha protein levels presence (or absence) of
estradiol. Lastly, we determined the effects of estradiol on the immune response by
measuring changes in behavior (lethargy), physiology (thermoregulation) and metabolism
(body weight), which are critical components of sickness and constitute an organized
response to infection (Dantzer, 2001)
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Experimental design
Experiment 1: Does estradiol influence the microglial response to LPS?
Animals. Thirty two C57Bl/6 female mice arrived on postnatal day P21 and were
kept in a 14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad
libitum food and water. All procedures were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by
the Institutional Animal Care and Use Committee.
Experimental Timeline. Animals received an E-mitter device, were
ovariectomized and implanted with a Silastic™ capsule filled with estradiol (50µg
E2/25µl sesame oil) or sesame oil on P35. A week later, on P42, animals received an
intraperitoneal injection of LPS (1.5mg/kg) or sterile saline within an hour prior to the
onset of the dark phase of the light:dark cycle. Brains were collected 24 hours postinjection.
Experiment 2: Does estradiol influence cytokine levels after LPS administration?
Animals. Forty-eight C57Bl/6 female mice arrived on postnatal day P21 and were
kept in a 14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad
libitum food and water. All procedures were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by
the Institutional Animal Care and Use Committee.
Experimental Timeline. Animals received an E-mitter device, were
ovariectomized and implanted with a silastic capsule filled with estradiol (50µg E2/25µl
sesame oil) or sesame oil on P35. A week later, on P42, animals received an
intraperitoneal injection of LPS (1.5mg/kg) or sterile saline within an hour prior to the

55

onset of the dark phase of the light:dark cycle. Plasma was collected at 6 hours and 24
hours post-injection.
Methods
Ovariectomy and capsule implantation. Animals were anesthesized with
isofluorane (3% at one l/min, inhaled) and a single incision was made to the dorsal skin
and the muscle layer to locate the uterine horns. Once identified, the uterine horns were
clamped, the ovaries were removed and the tips of the uterine horns were cauterized with
an Acu-Cautery (Acuderm Inc, Fort Lauderdale, FL). The muscle layer was sutured with
an absorbable suture (Catalog# J315; Ethicon, PR), and the incision was closed using
surgical wound clips (Catalog# 427631; Becton Dickinson, Sparks, MD). For capsule
implantation, a small incision was made to the skin layer of the neck and a 2.5cm long
silastic capsule (1.57mm I.D. × 3.18mm O.D; Dow Corning) filled with estradiol or
sesame oil was implanted (Knox et al., 2009). The incision was closed using surgical
wound clips. Mice were transferred to a heating pad to recover until they were fully
awake, and were returned to their home cage.
E-mitter implant. We measured locomotor activity and core body temperature by
implanting a G2 E-mitter device (E-mitter Respironics Mini-mitter, Bend, OR) in the
abdominal cavity of mice. The E-mitter was sutured to the abdominal muscle wall to
keep its placement stable. Prior to implantation, the E-mitter was washed with
Tergazyme, a detergent with protease enzyme activity. Following Tergazyme, E-mitters
were incubated in 3% glutaraldehyde to disinfect and sterilize the E-mitter, and rinsed
with sterile saline at least 3 times. Radio signals for locomotion and temperature were
recorded by a receiver board (ER-4000 energizer receiver) underneath the cage housing
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each animal and stored via Vital View Data Acquisition System (version 4.1; Mini
Mitter) on a personal computer. Data was collected in 2-min bins. The mice were allowed
to recover from E-mitter implant surgery for at least 1 wk before onset of the
experiments.
Immunocytochemistry for Iba1. Brains were collected and fixed in 4%
paraformaldehyde for 24 hours, followed by an incubation in 30% sucrose in 0.1M PBS
for at least 72 hours. Brains were sectioned coronally in 30µm thick sections using a
cryostat. Free-floating sections were rinsed for 3×5 min in 0.05M tris-buffered saline
(TBS) and also rinsed before each subsequent step, except between the blocking and
primary antibody steps. Brain sections were quenched in 30% hydrogen peroxide and
blocked in 20% normal goat serum. Sections were then incubated for 48 hours at 4°C in
primary antibody (Iba1) mixed in gel TBS. After 48 hours, sections were incubated for 90
mins at room temperature in a solution of biotinylated secondary antibody in gel TBS.
The Avidin-Biotin Complex (ABC) was used to bind a complex of streptavidin-biotin
peroxidase to the secondary antibody for 90 mins. The reaction was then developed with
diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA, USA) for 20 mins to
produce a colorimetric stain. Sections were mounted on gelatin-coated slides, dehydrated
and coverslipped with Polymount.
Microscopic analysis of Iba. Three photomicrographs of carefully matched
sections of the anteroventral periventricular area (AVPv), ventromedial nucleus of the
hypothalamus (VMH), arcuate nucleus (ARC) and thalamus (Thal) were taken from each
animal using a Nikon Optiphot-2 microscope connected to a QImaging Micropublisher
RTV 5.0 digital color camera (Surrey, BC, Canada). Iba1 staining was quantified in the
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AVPv, ARC, VMH and Thal using the ImageJ software (NIH Image, Scion Image) and
mean Iba1 staining was measured using the thresholding approach, which included
microglial cells on our plane of view, as well as processes of microglial cell bodies out of
our plane of view. This is a widely used broad approach to measure Iba1
immunoreactivity (Beynon & Walker, 2012). Morphometric analysis of individual
microglia was quantified using the Metamorph Neurite Outgrowth program (Molecular
Devices, West Chester, PA, USA; version 7.7). Using the Neurite Outgrowth software,
we measured changes in microglia morphometry by quantifying the number of microglia,
total cell body size, mean cell body area, total outgrowth, mean outgrowth, total
branches, and total processes.
Plasma. Trunk blood was collected into an EDTA (ethylenediaminetetraacetic
acid) treated tube (BD Vacutainer, Catalog # 367842) and placed on ice. Blood was
centrifuged at 4°C in a microcentrifuge (Eppendorf 5415R). After centrifugation, plasma
was aliquoted and stored in -80°C freezer until assayed. Estradiol levels were determined
using the mouse estradiol ELISA kit (Catalog# ES180S, Calbiotech, CA).
Cytokine protein quantification. Cytokine protein levels in plasma were measured
6h and 24h post injection. The 24h time point was selected to determine how cytokine
levels at this time point related to microglial changes. The 6h time point was selected
because, in a time-course profile of cytokine expression at the protein level, the 6h time
point was the optimal time point to measure the peak and/or gradual increase of our
cytokines of interest (Brown et al., 2010). Furthermore, 6h was the peak point at which a
single peripheral LPS injection caused significant breakdown of the blood brain barrier
(Brown et al., 2010). The levels of IL1-alpha, IL1-beta, IL6, IL10 and TNF-alpha were
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analyzed using the Luminex Multiplex Instrument Bio-Plex 200 system (Hercules, CA,
USA) from samples shipped to MMPC (Mouse Metabolic and Phenotyping Center) at the
University of Massachusetts Medical School
Statistics
To examine the effect of treatment (saline and LPS) and hormone (oil or
estradiol) on microglial morphology, cytokines, body weight and estradiol levels we used
a two-way ANOVA and corrected for multiple comparisons using Bonferroni
corrections.
Results
Estradiol enhances basal microglial reactivity in the VMH by influencing microglial
ramifications.
In the VMH, estradiol increases microglial reactivity at basal levels. This
estradiol-driven increase in microglial reactivity seems to be due to higher outgrowth,
which refers to microglial processes and branches (Fig. 2A). This outgrowth is the result
of microglial cells that have cell bodies in the photomicrograph’s plane of view but also
from microglia with cell bodies beyond our plane of view. This is an important
consideration because microglial ramifications extend in multiple directions and one
limitation of this approach is that, although microglia have 3-dimensional morphological
properties, we are quantitating microglial morphometric properties in a 2-dimension
plane of view. When we analyze microglial outgrowth looking only at ramifications
associated with a cell body in our 2-dimensional plane of view, we see that oil and
estradiol treated females show similar outgrowth at basal levels (Fig. 2E). In addition,
microglia undergo robust changes in morphology post-LPS regardless of the hormone
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environment (Fig. 2; A-H). After LPS, there was an increase in microglia cell numbers
(Fig.2B), increased soma size (Fig.2C, D) and a decrease in their overall outgrowth (Fig.
2E), which was mainly driven by a decrease in microglial branches (Fig. 2H). The
microglial ratio analysis suggests that the cells undergoing these drastic morphological
changes are resident microglial cells within the VMH; there is a robust decrease in the
number of basal or “surveying” microglia (ratio 0-0.99) and a concomitant increase in
“activated” microglia (ratio 3.00+; Fig. 3).
In the presence of estradiol, LPS fails to increase the number of microglia in the AVPv.
The effect of estradiol on microglia in the AVPv emerges after an LPS challenge.
LPS treatment in the presence of estradiol decreases microglial outgrowth (Fig. 5E).
There is a robust decrease in basal microglia (ratio 0.0-0.99) post-LPS in both oil and
estradiol females. Interestingly, oil-LPS treated females show an increase in all non-basal
microglial phenotypes (ratios 1.0-3.0+), while E2-LPS microglia only transition into
intermediate morphologies (Fig. 6). This might be in part explained by the fact that only
oil-LPS treated show an increase in overall microglial numbers after LPS, while
estradiol-LPS females do not (Fig. 5B).
Estradiol does not influence microglial reactivity in the ARC.
Estradiol does not seem to influence microglial morphology in the ARC. LPS
induces a robust transformation in microglial morphology regardless of hormonal milieu
(Fig. 8). However, microglial ratio analysis shows that there is a robust increase in
“activated” microglia post-LPS regardless of hormone environment, demonstrating that
the ARC responded to LPS treatment (Fig. 8).
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Estradiol does not influence any microglial morphological parameter following LPS in
the Thal.
In the Thal, only oil-LPS microglia showed a morphological transformation after
LPS treatment. Only in oil treated females, LPS increased microglial density (Fig. 11A),
microglial numbers (Fig. 11B), and cell body area (Fig. 11C-D). The microglial ratio
analysis suggests that in oil-LPS treated females, the cells undergoing these drastic
morphological changes are resident microglial cells within the Thal; there is 2-fold
decrease in the number of basal or “surveying” microglia (ratio 0-0.99), with a
concomitant increase in “activated” microglia (ratio 3.00+; Fig. 12). Interestingly,
microglia receiving E2-LPS show an increase in activated microglia in a similar
magnitude to oil-LPS females. However, E2-LPS microglia do not show the concomitant
decrease in basal microglia (Fig. 12).
LPS causes a stronger induction of specific cytokines in the presence of estradiol.
LPS causes a stronger induction of TNF-alpha and IL10 in the presence of
estradiol 6h post injection (Fig. 13D-E). On the other hand, IL6 was induced only in oilLPS females (Fig. 13C). There were no differences in the induction of IL1-alpha (Fig.
13A) and IL1-beta levels could not be determined (Fig.13B). By 24h post injection, TNFalpha and IL10 levels had returned to baseline (Fig. 13 I-J). However, IL6 continued to
be elevated in LPS treated animals, regardless of hormonal milieu (Fig. 13H) and ILalpha was down-regulated only in oil-LPS females (Fig. 13F).
LPS causes hypothermia in the presence of estradiol.
LPS causes hypothermia only in the presence of estradiol (Fig. 14). Importantly,
estradiol does not affect locomotor activity post-LPS, as both oil and estradiol treated
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females show the expected decrease in lethargy, a component of sickness behavior (Fig.
15).
LPS causes a stronger anorexic-response in the presence of estradiol.
LPS decreased the body weight in both oil and estradiol treated females.
However, body weight loss was stronger in estradiol treated females 6h post injection
(Fig. 16). However, by 24h post-injection oil-LPS and E2-LPS females showed similar
body weight loss (Fig. 17).

A

B

oil saline

oil LPS

D

C

E2 LPS

E2 saline

Figure 3.1. Representative photomicrographs of microglia in the ventromedial
hypothalamus (VMH) of ovariectomized pubertal female mice that received an oil or
estradiol capsule. Females treated with A) oil-saline. B) oil-LPS. C) estradiol-saline. D)
estradiol-LPS.
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Figure 3.2. The effects of lipopolysaccharide administration on microglial morphology in
the ventromedial hypothalamus (VMH) of ovariectomized pubertal mice that received an
oil or estradiol capsule (mean ± SEM). A) Microglial density. B) Number of microglia.
C) Total cell body area. D) Mean cell body area. E) Total outgrowth. F) Mean outgrowth.
G) Total number of processes. H) Mean number of branches.
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Figure 3.3. Microglial heterogeneity in the ventromedial hypothalamus (VMH) of
ovariectomized pubertal mice that received an oil or estradiol capsule (mean ± SEM).
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Figure 3.4. Representative photomicrographs of microglia in the anteroventral
periventricular nucleus (AVPv) of ovariectomized pubertal female mice that received an
oil or estradiol capsule. Females treated with A) oil-saline. B) oil-LPS. C) estradiolsaline. D) estradiol-LPS.
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received an oil or estradiol capsule (mean ± SEM). A) Microglial density. B) Number of
microglia. C) Total cell body area. D) Mean cell body area. E) Total outgrowth. F) Mean
outgrowth. G) Total number of processes. H) Mean number of branches.
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Figure 3.7. Representative photomicrographs of microglia in the arcuate nucleus (ARC)
of ovariectomized pubertal female mice that received an oil or estradiol capsule. Females
treated with A) oil-saline. B) oil-LPS. C) estradiol-saline. D) estradiol-LPS.
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Figure 3.9. Microglial heterogeneity in the arcuate nucleus (Arc) of ovariectomized
pubertal mice that received an oil or estradiol capsule (mean ± SEM).
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Figure 3.10. Representative photomicrographs of microglia in the thalamus (Thal) of
ovariectomized pubertal female mice that received an oil or estradiol capsule. Females
treated with A) oil-saline. B) oil-LPS. C) estradiol-saline. D) estradiol-LPS.
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Figure 3.13. The effects of lipopolysaccharide on cytokine levels in ovariectomized
pubertal mice that received an oil or estradiol capsule. Data was collected 6h (A-E) or
24h (F-J) post-injection (mean ± SEM).
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Figure 3.15. The effects of lipopolysaccharide administration on locomotion in
ovariectomized pubertal females that received an oil or estradiol capsule (mean ± SEM).
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Figure 3.18. Plasma estradiol levels of ovariectomized female mice implanted with an oil
or estradiol capsule (mean ± SEM).
Discussion
Nearly all immune cells of vertebrates and invertebrates express steroid hormone
receptors, suggesting a direct influence of steroids on immune function (Fish, 2008).
Estradiol can regulate microglial numbers, morphology and cytokine expression at basal
levels (Mor et al., 1999) and after an immune challenge (Vegeto et al., 2001). The role of
microglia in monitoring the brain microenvironment is particularly important during
sensitive periods of development. During pubertal development there are drastic changes
in the architecture of brain regions via cell genesis, cell death and synaptic remodeling
(Tremblay, Lowery, & Majewska, 2010)(Schafer et al., 2012). That means that during
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sensitive periods of development, microglia are particularly active, and further activation
by an immune challenge can remodel how glia and neurons interact permanently.
Estradiol has powerful anti-inflammatory and pro-inflammatory effects on microglia, and
the direction of estradiol’s effect is critically determined by sex, age and brain region.
Importantly, most of the anti-inflammatory effects of microglia are reported in cortical
brain regions or in the aging brain (Brown et al., 2010; Bruce-Keller et al., 2000;
Godbout et al., 2005; Johnson et al., 2006; Vegeto et al., 2006).
The present work suggests that estradiol enhances inflammation in pubertal
female mice in a brain region dependent manner. First, there are brain specific changes in
the morphometric properties of microglia at basal levels (i.e. in control females). In the
VMH, estradiol enhances basal microglial reactivity by increasing microglial outgrowth,
which allows microglial cells to survey a larger surface area. This increases their ability
to survey the microenvironment and respond faster or more efficiently to injury,
pathogens or toxins. On the other hand, estradiol blocks the ability of LPS to increase the
number of microglia following an immune challenge in the AVPv. This suggest sthat in
the AVPv, estradiol may attenuate microglial reactivity. This notion is supported by the
observation that estradiol prevents microglia from reaching a “fully activated”
morphology following LPS, which is not prevented in oil-LPS females. Instead, microglia
in E2-LPS females transform into “intermediate” phenotypes without ever reaching a
fully activated (e.g. phagocytic-like) state. Alternatively, it is possible that LPS
administration in the presence of estradiol, induces microglial cell death in the AVPv. In
fact, while there is an increase in microglial numbers in oil-LPS females there are no
signs of such induction in E2-LPS animals. Lastly, estradiol does not seem to modulate
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microglial morphology at basal nor after LPS administration. Overall, these data suggest
that: (1) the effects of the hormone milieu and LPS are brain-region dependent, and (2)
the interaction between the hormone milieu and LPS in the VMH and AVPv unfold
differently.
There are a few points we must consider when interpreting these data. First,
although the route of administration of estradiol used in this study rescues the effects of
ovariectomy on several markers of pubertal maturation (Clarkson et al., 2009), it is
unknown if the concentration of estradiol is within the physiological range for pubertal
mice. Therefore, there is a possibility that the level of estradiol administered to pubertal
animals is supra physiological. Secondly, the microglia data is the reflection of the
interaction between the hormone environment and an immune challenge at a single time
point (24h post injection). This is an important consideration because our behavioral,
physiological, cytokine and metabolic data showed dynamic changes in multiple
inflammation-relevant outcomes throughout the 24h collection period. Therefore, we
cannot exclude the possibility that the role of estradiol on microglial morphology is
temporally regulated. Third, in this study we did not investigate estrogen-receptor
expression in microglia. It is possible that estrogen receptors are expressed only in a
subset of microglia and that we might be overlooking subtle nuances in microglial
morphology by reporting the average profile of all microglia in a given region.
Microglial function includes the production of cytokines, elimination of cellular
debri via phagocytosis and antigen presentation. The ability of microglia to perform these
functions depend largely on the set of receptors that they express (Hanisch, 2013). We
consistently find that microglia adapt heterogeneous morphologies at basal levels and
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after an immune challenge. This is not surprising given that brain regions vary by
microglial density, morphology and expression of a substantial number of gene products,
although the functional implications need to be examined in more detail (Hanisch, 2013).
Microglial heterogeneity between brain regions can reflect the biochemical signature of
the microenvironment (Gertig & Hanisch, 2014). Amoeboid microglia (ratio 3.00+; large
cell bodies and nearly inexistent ramifications) are well positioned for phagocytic
functions, whereas microglia with stout processes (intermediate ratio 1.0-2.99) can
function as dendritic cells (Hanisch, 2013). Dendritic cells are the link between innate
and adaptive immunity, which can have implications for chronic neuroinflammatory
events, affecting brain processes well after the acute immune response has dissipated.
Our microglial ratio analysis allows us to differentiate subtle differences in the
heterogeneity of microglia within a brain region but the relative abundance of microglial
phenotypes within those categories can be altered if only a subset of microglia express
estrogen receptors.
It remains to be determined if estradiol regulates the expression of microglial
cytokine genes. In these experiments we focused only on microglial morphology, but
estrogen receptors are transcription factors and have the ability to regulate the microglial
cytokine profile at basal levels and after an immune challenge (Soucy et al., 2005)
(Brown et al., 2010). The notion that estradiol enhances inflammation during pubertal
development is supported by the cytokine, thermoregulatory and metabolic changes
observed in our animals. LPS causes a strong hypothermic response in the presence of
estradiol, which is not seen in oil-LPS treated females. Although fever is a typical
response to infection, hypothermia is only induced in severe cases of inflammation
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(Romanovsky et al., 1996). Estradiol increases the levels the pro-inflammatory cytokines
IL-1 beta, IL-6 and TNF-alpha released from peritoneal macrophages at basal levels and
following LPS-administration, compared to oil controls (Calippe et al., 2010). Our
cytokine levels show a similar secretion pattern 6h post injection. Also, LPS decreased
the body weight in both oil and estradiol treated females, but body weight loss was
greater in estradiol treated females 6h post injection (Fig. 15). However, by 24h postinjection oil-LPS and E2-LPS females showed similar body weight loss, suggesting a
time-dependent effect of estradiol on metabolism and/or feeding circuitry. The centers
controlling movement, thermoregulation and appetite are found in the central nervous
system. Regardless of where the immune response is first induced (centrally or
peripherally), these signaling pathways converge in the brain. Therefore, the
quantification of sickness outcomes provides indirect support to the notion that estradiol
enhances the inflammatory response to LPS during pubertal development.
The present work suggests that estradiol enhances inflammation in pubertal
female mice in a brain region and time dependent manner. Understanding the interaction
between the endocrine, immune and central nervous systems in females may shed light
into factors that promote a sex bias in the prevalence of mood and immune-related
disorders, whose onset and progression in females emerge during the reproductive years.
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CHAPTER 4
BLOCKING ESTRADIOL SYNTHESIS ATTENUATES NEUROINFLAMMATION
DURING PUBERTAL DEVELOPMENT IN FEMALE MICE
Introduction
There is a dynamic interaction between the immune, endocrine, and central
nervous systems. In females, this interaction becomes more pronounced during the
reproductive years. Puberty is a maturational period in which an organism achieves
reproductive competence (Sisk & Foster, 2004). One of the hallmarks of puberty is the
secretion of steroid hormones. Estradiol is a potent steroid hormone and has pleiotropic
functions (Brown et al., 2010). Nearly all immune cells express estrogen receptors, which
suggests that estradiol can have a direct influence on immune function (Ottaviani,
Malagoli, & Franceschi, 2007).
Microglia are the resident immune cells of the brain, and they experience agedependent changes in their morphology (Schwarz et al., 2012) and gene expression
profile (Brown et al., 2010). Microglia displaying basal morphology show differences in
the expression of surface markers associated with pro-inflammatory or anti-inflammatory
outcomes (Crain, Nikodemova, & Watters, 2013). Developmental expression of Toll-like
receptor 4 (TLR4), which transduces signaling associated with bacterial infections (e.g.
LPS), increases ~4 fold during the peripubertal period (whole brain homogenates)
(Christensen, Woods, Carmody, Caughey, & Peterson, 2014). In addition, the expression
of estrogen receptor alpha in microglia increases 2-3 fold during the peripubertal period
(Crain et al., 2013). Overall, these data may suggest that the peripubertal period is an
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active and dynamic phase where the immune and endocrine systems may interact to
refine brain networks.
Estrogen biosynthesis is catalyzed by aromatase (Yue & Brodie, 1997).
Aromatase is the rate limiting enzyme for estradiol synthesis and it can be inhibited by
aromatase inhibitors like formestane. Formestane inhibits aromatase by acting as a
steroidal substrate analog (Simpson & Dowsett, 2002) (Yue & Brodie, 1997). In vitro,
formestane causes sustained inhibition of aromatase activity in ovarian rat cells and
human placental cells, and it is not reversed even after removal of the inhibitor (Yue &
Brodie, 1997) (Yue & Brodie, 1997). In vivo, formestane decreases estradiol levels
(Amateau, Alt, Stamps, & McCarthy, 2004a) (Dean et al., 2012) (Yue & Brodie, 1997),
and it does not stimulate aromatase mRNA synthesis (Yue & Brodie, 1997).
In the previous chapter (Chapter 3) we saw that estradiol treatment to
ovariectomized female mice enhances inflammation. Therefore, we designed the
following experiments to test the hypothesis that blocking estradiol synthesis attenuates
LPS-induced neuro-inflammation in female mice. We determined the effects of oil
(vehicle control) or formestane (aromatase inhibitor) in gonadally intact females and
quantified changes in the morphometric properties of microglia. We measured microglial
reactivity in brain regions that regulate female reproduction, show a high density of
estrogen receptors and undergo considerable architectural changes during puberty like the
ventromedial nucleus of the hypothalamus (VMH), the anteroventral periventricular
region (AVPv), the arcuate nucleus (Arc). We also analyzed the periventricular nucleus
of the thalamus, a thalamic nucleus that that expresses low levels of estrogen receptors
(Pérez et al., 2003), and is involved in processing information from the autonomic
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nervous system (Kirouac, 2015). In addition, we examined the effects of blocking
estradiol synthesis on IL1-alpha, IL1-beta, IL6, IL10 and TNF-alpha protein levels.
Lastly, we determined the effects of formestane on the immune response by measuring
changes in behavior (lethargy), physiology (thermoregulation) and metabolism (body
weight), which are critical components of sickness and constitute an organized response
to infection (Dantzer, 2001).
Experimental Design
Experiment 1: Does formestane (aromatase inhibitor) influence microglial reactivity?
Animals. Thirty two C57Bl/6 female mice arrived on postnatal day P21 and were
kept in a 14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad
libitum food and water. All procedures were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by
the Institutional Animal Care and Use Committee.
Experimental Timeline. Animals were injected daily with formestane or sesame oil from
P35 through P42 at a dose of 20µg/kg. On P42, mice were injected with saline or LPS
(1.5mg/kg) within an hour prior to the onset of the dark phase of the dark:light cycle.
Brain, plasma and ovarian tissue was collected on P43 (24h post-injection).
Experiment 2: Does formestane (aromatase inhibitor) influence cytokine levels?
Animals. Forty-eight C57Bl/6 female mice arrived on postnatal day P21 and were
kept in a 14:10 hour cycle (lights off at 10am), housed in groups of four, and with ad
libitum food and water. All procedures were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by
the Institutional Animal Care and Use Committee.
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Experimental Timeline. Animals were injected with formestane or sesame oil for
7 consecutive days, starting on P35 through P42 at a dose of 20µg/kg. On P42, mice were
injected with saline or LPS (1.5mg/kg) within an hour prior to the onset of the dark phase
of the dark:light cycle. Brain, plasma and ovarian tissue was collected on P42 (6h postinjection) and P43 (24h post-injection).
Statistics.
To examine the effect of treatment (saline and LPS) and drug (oil or formestane) on
microglial morphology, cytokines and body weight we used a two-way ANOVA and
corrected for multiple comparisons using Bonferroni corrections.
Methods
E-mitter implant. We measured locomotor activity and core body temperature by
implanting a G2 E-mitter device (E-mitter Respironics Mini-mitter, Bend, OR) in the
abdominal cavity of mice on P28. The E-mitter was sutured to the abdominal muscle wall
to keep its placement stable. Prior to implantation, the E-mitter was washed with
Tergazyme, a detergent with protease enzyme activity. Following the Tergazyme wash,
E-mitters were incubated in 3% glutaraldehyde to disinfect and sterilize the E-mitter, and
rinsed with sterile saline at least 3 times, as per manunfacturer’s instructions. Radio
signals for locomotion and temperature were recorded by a receiver board (ER-4000
energizer receiver) underneath the cage housing each animal and stored via Vital View
Data Acquisition System (version 4.1; Mini Mitter) on a personal computer. Data were
collected in 2-min bins. The mice were allowed to recover from E-mitter implant surgery
for at least 1 wk before onset of the experiments.
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Aromatase inhibitor. Animals were injected with formestane or sesame oil for 7
consecutive days, starting on P35 through P42 at a dose of 20µg/kg. This dose decreases
estradiol levels in vivo (Amateau, Alt, Stamps, & McCarthy, 2004b), and impacts
electrophysiological properties in Purkinje neurons like in input resistance and membrane
capacitance (Dean et al., 2012). On P42, females were injected with saline or LPS and
brain, plasma and ovarian tissue was collected on P42 (6h post-injection) and P43 (24h
post-injection).
Immunocytochemistry for Iba1. Brains were collected and fixed in 4%
paraformaldehyde for 24 hours, followed by an incubation in 30% sucrose in 0.1M PBS
for at least 72 hours. Brains were sectioned coronally in 30µm thick sections using a
cryostat. Free-floating sections were rinsed for 3×5 min in 0.05M tris-buffered saline
(TBS) and also rinsed before each subsequent step, except between the blocking and
primary antibody steps. Brain sections were quenched in 30% hydrogen peroxide and
blocked in 20% normal goat serum. Sections were then incubated for 48 hours at 4°C in
primary antibody (Iba1) mixed in gel TBS. After 48 hours, sections were incubated for 90
mins at room temperature in a solution of biotinylated secondary antibody in gel TBS.
The Avidin-Biotin Complex (ABC) was used to bind a complex of streptavidin-biotin
peroxidase to the secondary antibody for 90 mins. The reaction was then developed with
diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA, USA) for 20 mins to
produce a colorimetric stain. Sections were mounted on gelatin-coated slides, dehydrated
and coverslipped with Polymount.
Microscopic analysis of Iba. Three photomicrographs of carefully matched
sections of the anteroventral periventricular area (AVPv), ventromedial nucleus of the
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hypothalamus (VMH), arcuate nucleus (ARC) and periventricular thalamus (pvThal)
were taken from each animal using a Nikon Optiphot-2 microscope connected to a
QImaging Micropublisher RTV 5.0 digital color camera (Surrey, BC, Canada). Iba1
staining was quantified in the AVPv, ARC, VMH and Thal using the ImageJ software
(NIH Image, Scion Image). Images were converted to grayscale and thresholded using
the Max Entropy function in ImageJ. We quantified mean Iba1 staining, which included
microglial cells on our plane of view, as well as processes of microglial cell bodies out of
our plane of view. This is a widely used approach to quantify Iba1 immunoreactivity
(Beynon & Walker, 2012) (Cherry et al., 2015). Morphometric analysis of individual
microglia was quantified using the Metamorph Neurite Outgrowth program (Molecular
Devices, West Chester, PA, USA; version 7.7). Using the Neurite Outgrowth software,
we measured changes in microglia morphology by quantifying total cell body size, mean
cell body area, total outgrowth, mean outgrowth, total branches, total processes and total
number of microglia.
Plasma. Trunk blood was collected into an EDTA (ethylenediaminetetraacetic
acid) treated tube (BD Vacutainer, Catalog #367842) and placed on ice. Blood was
centrifuged at 4°C and 10x rpm in a microcentrifuge (Eppendorf 5415R). After
centrifugation, plasma was aliquoted and stored in a -80°C freezer until assayed.
Cytokine protein quantification. Cytokine protein levels in plasma were measured
6h and 24h post injection. The 24h time point was selected to determine how cytokine
levels at this time point related to microglial changes. The 6h time point was selected
because, in a time-course profile of cytokine expression at the protein level, the 6h time
point was the optimal time point to measure the peak and/or gradual increase of our
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cytokines of interest (Brown et al., 2010). Furthermore, 6h was the peak point at which a
single peripheral LPS injection caused significant breakdown of the blood brain barrier
(Brown et al., 2010). The levels of IL1-alpha, IL1-beta, IL6, IL10 and TNF-alpha were
analyzed using the Luminex Multiplex Instrument Bio-Plex 200 system (Hercules, CA,
USA) from samples shipped to MMPC (Mouse Metabolic and Phenotyping Center) at the
University of Massachusetts Medical School.
Results
An aromatase inhibitor decreases basal microglial reactivity in the VMH.
In the VMH, formestane decreases basal microglial reactivity (Fig. 2A). This
effect is driven by a decrease in microglial outgrowth, which refers to microglial
processes and branches (Fig. 2E). The decrease in total microglial outgrowth as a result
of blocking estradiol synthesis is caused by a decrease in microglial branches (Fig. 2H).
Also, microglia undergo robust changes in morphology after LPS exposure, regardless of
the hormonal milieu. These changes include a 2-fold increase in microglial cell body area
(Fig. 2C-D) changes in microglial ramifications (Fig. 2E-H), and a nearly 2-fold increase
in microglial numbers (Fig. 2B). Analysis of microglial phenotypes suggests that
microglial cells undergoing such morphological changes are resident cells within the
VMH. There is a robust decrease in the number of basal or “surveying” microglia (ratio
0-0.99) and a concomitant increase in “activated” microglia (ratio 3.0+) (Fig. 3).
An aromatase inhibitor does not influence microglial reactivity in the AVPv.
Microglial morphology is not altered by estradiol in the AVPv. In contrast to the
VMH, formestane does not influence microglial outgrowth at basal levels nor after LPS
exposure (Fig. 5E). Regardless of hormone environment, LPS transforms microglial
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morphology by increasing the cell body area (Fig.5C-D) and increasing the number of
microglia (Fig. 5B), and a 2-fold increase in the number of processes (Fig. 5G).
Furthermore, analysis of the relative microglia phenotype shows microglial heterogeneity
in the AVPv. Interestingly, the number of “surveying” microglia (ratio 0-0.99) is similar
to saline control groups, whereas there is an increase in intermediate and activated
microglial phenotypes (Fig. 6).
An aromatase inhibitor decreases basal microglial reactivity in the ARC.
In the ARC, formestane decreases basal microglial reactivity (Fig. 8A). This
effect is driven by a decrease in microglial branches (Fig. 8H). In addition, microglia
undergo robust changes in morphology after LPS exposure, regardless of hormone
environment. LPS increases 2-fold the size of microglial cell body (Fig. 8C-D), it induces
changes in microglial ramifications (Fig. 8E-H), and it increases microglial numbers (Fig.
8B). Analysis of the relative microglia phenotype suggests that microglial cells
undergoing such morphological changes are resident cells within the ARC; there is a 2fold decrease in the number of basal or “surveying” microglia (ratio 0-0.99) and a
concomitant increase in “active” microglia (ratio 3.0+) (Fig. 9).
An aromatase inhibitor decreases microglial reactivity in the Thal.
In the thalamus, there is a main effect of formestane on microglial morphology
(Fig. 11A). LPS increases microglial density in oil treated females, while LPS has no
effect on microglia treated with an aromatase inhibitor (Fig. 11A). In contrast with the
VMH and ARC, the decrease in reactivity in the Thal seems to be partially driven by
microglial cell bodies (Fig. 11D) and the total number of microglial processes (Fig. 11G).
Analysis of microglial phenotypes suggests that microglial cells within the Thal are
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heterogeneous in morphology but there are no changes in their distribution after LPS
exposure (Fig. 12).
An aromatase inhibitor attenuates the induction of pro-inflammatory cytokines.
LPS causes a strong induction of the pro-inflammatory cytokines IL1-beta, IL6
and TNF-alpha 6h post-injection, compared to their saline controls (Fig. 13B, C, E).
However, blocking estradiol synthesis attenuates the induction of these cytokines,
suggesting that circulating estradiol causes a stronger inflammatory response.
Furthermore, although LPS increased the levels of the anti-inflammatory cytokine IL10,
the hormone environment did not modulate its induction (Fig. 13D). The LPS-driven
upregulation of all of these cytokines is time-dependent. By 24h post-injection, TNFalpha was still significantly higher in animals that retained the ability to secrete estradiol,
while it had returned to baseline in formestane treated animals (Fig. 13J). On the other
hand, IL10 was not significantly different in animals that retained the ability to secrete
estradiol, while it was still upregulated in formestane treated animals Fig. 13I).
LPS causes hypothermia in the presence of estradiol, while an aromatase inhibitor
attenuates it.
LPS causes hypothermia only in females that retained the ability to secrete
estradiol (oil controls). However, blocking estradiol synthesis in gonadally intact females
attenuates they hypotermic response (Fig. 14). Interestingly, LPS causes fever but the
hormone environment does not seem to influence the time of induction or the duration of
the fever (Fig. 14). Lethargy is another component of sickness and as expected, LPS
reduced locomotion. However, the hormone environment did not influence locomotion
(Fig. 15). In a similar pattern, LPS decreased body weight in both oil and formestane
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treated females at 6h (Fig. 16) and 24h (Fig. 17) post-injection, compared to saline
vehicle controls but the hormonal milieu did not influence it.

A

B

oil saline

oil LPS
D

C

formestane saline

formestane LPS

Figure 4.1. Representative photomicrographs of microglia in the ventromedial
hypothalamus (VMH) of gonadally intact pubertal female mice that received oil or an
aromatase inhibitor. Females treated with A) oil-saline. B) oil-LPS. C) formestane-saline.
D) formestane-LPS.
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Figure 4.2. The effects of lipopolysaccharide on microglia in the ventromedial
hypothalamus (VMH) of gonadally intact pubertal female mice that received oil or an
aromatase inhibitor (mean ± SEM). A) Microglial density. B) Number of microglia. C)
Total cell body area. D) Mean cell body area. E) Total outgrowth. F) Mean outgrowth. G)
Total number of processes. H) Mean number of branches.
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SEM).
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Figure 4.4. Representative photomicrographs of microglia in the anteroventral
periventricular area (AVPv) of gonadally intact pubertal female mice that received oil or
an aromatase inhibitor. Females treated with A) oil-saline. B) oil-LPS. C) formestanesaline. D) formestane-LPS.
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Figure 4.6. Microglial heterogeneity in the anteroventral periventricular area (AVPv) of
gonadally intact pubertal female mice that received oil or an aromatase inhibitor (mean ±
SEM).

96

B

A

oil saline

oil LPS

D

C

formestane saline

formestane LPS

Figure 4.7. Representative photomicrographs of microglia in the arcuate nucleus (Arc) of
gonadally intact pubertal female mice that received oil or an aromatase inhibitor. Females
treated with A) oil-saline. B) oil-LPS. C) formestane-saline. D) formestane-LPS.
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Figure 4.10. Representative photomicrographs of microglia in the thalamus (Thal) of
gonadally intact pubertal female mice that received oil or an aromatase inhibitor. Females
treated with A) oil-saline. B) oil-LPS. C) formestane-saline. D) formestane-LPS.
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Figure 4.11. The effects of lipopolysaccharide on microglia in the thalamus (Thal) of
gonadally intact pubertal female mice that received oil or an aromatase inhibitor (mean ±
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Figure 4.13. The effects of lipopolysaccharide on cytokine levels in gonadally intact
pubertal females that received oil or an aromatase inhibitor at 6h (A-E) or 24h (F-J)
(mean ± SEM).
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Figure 4.14. The effects of lipopolysaccharide administration on temperature in gonadally
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Figure 4.15. The effects of lipopolysaccharide administration on locomotion in gonadally
intact pubertal females that received oil or an aromatase inhibitor (mean ± SEM).
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Figure 4.16. The effects of lipopolysaccharide on body weight in gonadally intact
pubertal females that received oil or an aromatase inhibitor; data collected 6h after saline
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Figure 4.17. The effects of lipopolysaccharide on body weight in gonadally intact
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saline or LPS injection (mean ± SEM).
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Discussion
Nearly all immune cells of vertebrates and invertebrates express steroid hormone
receptors, suggesting a direct influence of steroids on immune function (Fish, 2008).
Estradiol can regulate microglial numbers, morphology and cytokine expression at basal
levels (Mor et al., 1999) and after an immune challenge (Vegeto et al., 2001). Overall,
these data suggest that ovarian secretions, particularly estradiol, enhance the immune
response during pubertal development. There are brain-region specific changes in the
morphometric properties of microglia at basal levels. In the VMH and the Arc, estradiol
enhances microglial reactivity, while the aromatase inhibitor formestane decreases it. The
decrease in microglial reactivity is driven by a decrease in microglial outgrowth,
particularly the number of microglial branches. This results in a reduced ability of
microglia to survey a larger area. On the other hand, microglial cells in the AVPv were
activated by LPS but were not affected by estradiol. The differential modulation of the
hormone environment on microglia may reflect an interaction between the specific
microglial transcriptional profile and the biochemical signature of the microenvironment
within each brain region (Gertig & Hanisch, 2014). Analysis of the immune and
endocrine transcription profile of cells within these microdissected regions could inform
the basis for differences in microglial morphology and pattern of activation.
Estradiol increases the levels the pro-inflammatory cytokines IL-1 beta, IL-6 and
TNF-alpha released from peritoneal macrophages at basal levels and following LPSadministration, compared to oil controls (Calippe et al., 2010). Consistent with this, we
observed that LPS caused a strong induction of the pro-inflammatory cytokines IL1-beta,
IL6 and TNF-alpha in animals that had the ability to secrete estradiol, while blocking
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estradiol synthesis attenuated the induction of these cytokines. Overall, these data may
suggest that estradiol enhances inflammation by inducing the transcription of proinflammatory genes.
Sickness is a non-specific consequence of infection that is induced by a variety of
pathogens ranging from bacteria to viruses and parasites (McCusker & Kelley, 2013).
The centers regulating locomotor activity, thermoregulation and appetite are in the central
nervous system. The notion that estradiol enhances inflammation during pubertal
development is supported by the thermoregulatory and metabolic changes observed
following LPS. LPS causes hypothermia in animals that can secrete ovarian estradiol.
However, blocking estradiol synthesis in gonadally intact females attenuates the
hypothermic response. Fever is a typical response to infection, but hypothermia is only
induced in severe cases of inflammation (Romanovsky et al., 1996). Regardless of where
the immune response is first induced (centrally or peripherally), these signaling pathways
converge in the brain.
Similar to the Chapter 3, our microglial data is the reflection of the interaction
between the hormone environment and an immune challenge at a single time point (24h
post injection). However, we know that there are dynamic changes in multiple
inflammation-relevant outcomes throughout the 24h collection period based on our
behavioral, physiological and metabolic data. Therefore, we cannot exclude the
possibility that the role of estradiol on microglial morphology is temporally regulated. In
addition, we did not investigate estrogen-receptor expression in microglia. It is possible
that estrogen receptors are expressed only in a subset of microglia and that we might be
overlooking subtle nuances in microglial morphology by reporting the average profile of
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all microglia in a given region. Our microglial ratio analysis partly addresses this issue
and highlights the notion of microglial heterogeneity within and between brain regions.
Some of the functions of microglia include the production of cytokines, elimination of
cellular debri via phagocytosis and antigen presentation. The ability of microglia to
perform these functions depend largely on the set of receptors they express (Hanisch,
2013). We consistently find that microglia adapt heterogeneous morphologies at basal
levels and after an immune challenge. This is not surprising given that brain regions vary
by microglial density, morphology and expression of a substantial number of gene
products, although the functional implications need to be examined in more detail
(Hanisch, 2013). The next set of experiments should investigate estrogen receptor
expression in microglia and its co-expression with activation markers within each region
of interest.
Together, these data suggest that estradiol enhances inflammation during pubertal
development in female mice. This notion is supported by brain-region dependent changes
in microglial morphology, increased secretion of pro-inflammatory cytokines in the
periphery and a strong hypothermic response caused by LPS in the presence of ovarian
secretions. The present work could have implications for understanding the underlying
neurobiology of sensitive periods, particularly areas that express high levels of estrogen
receptors and undergo significant remodeling during pubertal development.
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CHAPTER 5
DISCUSSION
Overview
There is a dynamic interaction between the immune, endocrine, and central
nervous systems. The main function of the immune system is to protect the organism
from pathogens by engaging a network of organs, cells and signaling molecules.
However, emerging data suggest that immune signaling in the brain is necessary for
normal developmental processes. Microglia, the resident-immune cells of the brain, are
critical in supporting the full development of neural circuits during sensitive periods of
development. Sensitive periods of development are time windows during which the
effects of experience are unusually strong (Knudsen, 2004). Therefore, over-activation of
the immune system during this period can alter the typical trajectory of maturing neural
circuits.
In the past, our laboratory has seen that an immune challenge (lipopolysaccharide;
LPS) during puberty alters how females respond to hormone treatment in adulthood. The
long-term effect of this immune challenge is only seen when LPS is administered during
puberty. Interestingly, removing the ovaries prior to administering LPS during pubertal
development protects females from the detrimental effects of LPS. This suggests that
ovarian secretions might be conferring vulnerability to LPS.
Consistent with the behavioral observations mentioned above, there is a
differential microglial reactivity between adult and pubertal females treated with LPS;
pubertal females show increased microglial reactivity in hypothalamic areas associated
with reproduction, compared to adult females receiving the same treatment (Holder &
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Blaustein, 2017). Higher microglial reactivity in pubertal animals could be explained in
part by the fact that at basal levels (no immune stressor), gonadally intact pubertal
females display a predominantly hyper-ramified microglia, while gonadally intact adult
animals show a predominantly hypo-ramified phenotype (Holder & Blaustein, 2017).
It is unknown if steroids of ovarian source are implicated in vulnerability to LPS
during the pubertal sensitive period. Our core hypothesis was that estradiol is the
proximate cause in conferring vulnerability to LPS by regulating microglial reactivity.
Since microglia express estrogen receptors (Sierra et al., 2008), we determined the effects
of LPS in the presence or absence of estradiol by manipulating the hormone environment
The effect of estradiol on microglia reactivity could have been reflected in at least three
different ways: (a) changes in the overall number of microglia, (b) differences in
microglial cell body size and/or, (c) differences in microglial outgrowth. The results
presented in this dissertation excluded possibilities “a” and “b”, and suggested that the
role of estradiol during pubertal maturation is via increasing microglial outgrowth.
Greater levels of microglial outgrowth support complex levels of arborization in
microglia, which might serve to enhance immune surveillance in brain regions
undergoing maturation. In the next sections I will elaborate on the main findings of this
dissertation, my working model and proposed mechanisms. Lastly, I will articulate the
implications of these findings, particularly in light of the interaction between the
hormone environment and the immune system during sensitive periods of development.
Main Findings
The core findings of this dissertation are:
1. Estradiol affects microglial reactivity by increasing microglial outgrowth.
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2. There is heterogeneity in microglia reactivity between brain regions.
3. There is heterogeneity in microglia reactivity within brain regions after immune
activation.
4. LPS causes a strong hypothermic response only in the presence of estradiol.
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FIGURE 5.1 Schematic illustration of the central idea presented in this dissertation.
Proposed Model and Functional Significance
In view of the evidence presented in this dissertation, I have created a working
model that summarizes our understanding of how an immune challenge during the
pubertal sensitive period can have long-lasting effects on behavior in the presence of
estradiol. The first part of this working model depicts an increase in estradiol levels as
animals transition into puberty. This elevation increases microglial outgrowth, which
results in enhanced immune surveillance by microglia in maturing brain regions.
In this working model, I propose that the estradiol-driven increase in microglial
outgrowth might serve to: (1) facilitate direct physical contact with neuronal synapses, or
(2) allow microglia to react faster to an immune challenge (or any perturbations that
might be detrimental to the brain).
One hypothesis is that the function of estradiol-driven increase in microglial
outgrowth could facilitate higher levels phagocytic activity within microglial
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ramifications. It been shown that basal microglia are capable of phagocytosis during
sensitive periods of development via the formation of phagocytic cups (Perezpouchoulen, Vanryzin, & Mccarthy, 2015). Phagocytic cups are round structures of actin.
The rat cerebellum undergoes major anatomical changes within the first three postnatal
weeks, and this developmental period coincides with the appearance of basal microglia
performing phagocytic functions, primarily via phagocytic cups at the distal ends of
microglial ramifications (Perez-pouchoulen et al., 2015). Interestingly, these phagocytic
cups co-label with cleaved caspase-3, suggesting that these cups are engulfing apoptotic
cell elements (Perez-pouchoulen et al., 2015). There is a significant elevation in
phagocytic cups as the cerebellum develops, which suggests that the increase in
phagocytic cups might be functionally associated with the appropriate development of the
cerebellum via synaptic prunning. In female mice, estradiol enhances microglial
outgrowth providing microglia with a greater area ability to survey their
microenvironment. It is possible, that the observed elevation in microglial outgrowth
might be necessary to facilitate a higher numbers of phagocytic cups. This could be one
way by which estradiol can help the pruning of neuronal synapses during development. If
the function of increased microglial outgrowth is to facilitate the elimination of neuronal
synapses in the developing brain, it should follow that there is an elevated number of
phagocytic cups only in females that received estradiol treatment. This line of evidence
would suggest that estradiol-driven effects in microglia play a role in the refinement of
brain circuits.
Alternatively, an estradiol-driven enhanced immune surveillance via increased
microglial outgrowth could be via regulation of genes involved in cytoskeletal integrity.
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When the immune system is activated, microglia undergo a rapid change in morphology.
The Iba1 protein is a is critical for the process of membrane ruffling in microglia, which
is a critical component of the morphological changes observed in microglia after immune
activation (Sasaki, Ohsawa, Kanazawa, Kohsaka, & Imai, 2001). The process of
membrane ruffling refers to the assembly of a network of newly polymerized actin
filaments that facilitates cell motility. Iba1 physically binds to F-actin and cross-links
actin filaments, which results in closely spaced actin bundles (Ohsawa, Imai, Kanazawa,
Sasaki, & Kohsaka, 2000). Since Iba1 is an actin regulatory protein and the Iba1 gene
contains an estrogen response element, it is possible that the estradiol-driven changes in
microglial outgrowth are the result of downstream regulation of cytoskeletal genes via
Iba1. One assumption underlying this hypothesis is that, in addition to regulating Iba1,
estradiol must be increasing the expression of immune-related genes at ramification sites
(e.g. TLR4 receptor). These two events must be necessary to allow microglia to react
faster to perturbations in the microenvironment. We can only speculate on this issue
because our microglial results were taken at a single time point. However, the higher
levels of pro-inflammatory cytokines seen at an earlier time point (6h) and the significant
drop in temperature following LPS administration, observed only in estradiol treated
females support this possibility. These two events provide indirect data about the severity
of the immune response in animals exposed to estradiol at the time of LPS. It is
reasonable to predict that microglia would react in a similar direction as other cytokinesecreting immune cells, given their common origin.
The final part of our working model as it relates to the long-term remodeling of
brain circuits as a result of an immune challenge remains to be tested. However, the
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functional significance of a stronger immune response to LPS only in the presence of
estradiol could be informing events leading to cell death. The basis for this interpretation
comes from the observation that animals exposed to LPS during puberty showed
decreased levels of estrogen receptor in adulthood (Ismail et al., 2011). Overall, this
model proposes that estradiol enhances surveillance by microglia in brain regions
maturing during puberty, but over-activation of the immune system may remodel these
regions long term, possibly by inducing the cell death of estrogen receptor positive cells.
Caveats
First, the experiments presented in this dissertation were designed to specifically
test or challenge the hypothesis that estradiol was the proximate cause of vulnerability to
LPS in pubertal animals. The estradiol capsule replacement experiment and the aromatase
inhibitor experiment suggest that estradiol is driving the neuroinflammatory effects seen
during pubertal development. However, in the ovarian secretion experiment (Chapter
2),the effects of ovarian secretions were not as robust as in the estradiol capsule or
aromatase inhibitor experiments. This discrepancy might be the due to different
concentrations of estradiol. Ovarian estradiol is essential for mounting an appropriate
immune response to LPS (Soucy et al., 2005), but it has also been shown estradiol can
have anti-inflammatory or pro-inflammatory effects on the immune response based on
the concentration of the hormone (Gottfried-Blackmore et al., 2008). In vitro, LPS
induces phagocytic activity in microglial cells, as measured by fluorescent bead uptake
by microglia (Bruce-Keller et al., 2000). Medium-doses of estradiol block microglial
phagocytic activity close to saline-treated cells. However, low and high doses of estradiol
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have no effect on microglial phagocytic activity, which means that they show similar
levels of phagocytosis as hormone-deprived LPS cells (Bruce-Keller et al., 2000).
Future Directions
Microglia belong to the macrophage lineage, which means that they are long-lived
cells and are well-positioned to influence neural circuits permanently. Much work
remains to be done to understand the neurobiology of sensitive periods, their onset, their
progression and closure and the potential role of microglial cells in these processes.
There is a general notion that microglia are the only immune cells found in the
central nervous system and that non-macrophage immune cells infiltrate the brain
parenchyma from the periphery. One way by which this occurs is by chemokine
signaling. Chemokines are proteins involved specifically in chemotaxis. Chemokines
signal and attract cells of the innate and adaptive immune system to sites of
inflammation. A specific analysis of the effects of estradiol on microglial transcriptomes,
adaptive immunity and/or chemokines could help dissect the positive and negative
signals that result in a remodeling of a neural circuits during sensitive periods. Each one
of these areas could alter typical maturation processes by inducing cell death, cell
genesis, synaptic pruning, and cellular differentiation. Emerging data suggest that
systemic inflammation has a significant role in the progression of chronic
neurodegenerative disease. Data suggest that transduction of inflammatory signals from
the periphery to the brain can be deleterious if the acute insult is sufficiently robust, as in
severe sepsis.
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Closing Remarks
The work presented in this dissertation shows that estradiol increases basal
microglial reactivity, primarily by increasing microglial outgrowth. The central idea
around the main findings presented in this dissertation suggests that estradiol enhances
immune surveillance during the pubertal sensitive period. Emerging data suggest that
microglia play a critical role in shaping neural circuits throughout development via
synaptic pruning, phagocytosis, cell death and cell genesis. However, over-activation of
the immune system during this period via an immune challenge, results in a severe
immune response, which can permanently reorganize brain circuits undergoing
maturation. Increased microglial outgrowth, results in a greater ability of microglia to
survey their microenvironment, which might be functionally relevant for areas
undergoing maturation during pubertal development. Importantly, in the brain regions of
interest, enhanced immune surveillance is not achieved by increased number of
microglial cells, or microglia with larger cell bodies. Overall, the results presented in this
dissertation could serve as a basis for understanding how other inflammatory insults can
converge on immune signaling during puberty and the role of ovarian secretions in
vulnerability during this sensitive period of development. Understanding the interaction
between the endocrine, immune and central nervous systems may shed light into factors
that promote a sex bias in the prevalence of mood and immune-related disorders, whose
onset and progression in females emerge during the reproductive years.
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